Adipose Tissue Dysfunction Related to Climate Change and Air Pollution: Understanding the Metabolic Consequences

✅ 全文

与气候变化和空气污染相关的脂肪组织功能障碍:理解其代谢后果

作者 Radoslav Stojchevski; Preethi Chandrasekaran; Nikola Hadzi‐Petrushev; Mitko Mladenov; Dimiter Avtanski 期刊 International Journal of Molecular Sciences 发表日期 2024 ISSN 1422-0067 DOI 10.3390/ijms25147849 类型 原创研究 (Original Research)

📄 中文摘要 Chinese Abstract

中文
肥胖是一种以能量失衡导致脂肪过度堆积为特征的全球性流行病,显著增加了2型糖尿病(T2DM)等代谢性疾病的发病风险。脂肪组织——特别是白色脂肪组织(WAT)和棕色脂肪组织(BAT)——在能量储存、体温调节和代谢稳态中发挥着核心作用。BAT富含解偶联蛋白1(UCP1),通过产热作用促进能量消耗,与肥胖呈负相关。越来越多的证据表明,气候变化和空气污染会破坏脂肪组织功能,导致肥胖增加和代谢功能障碍。全球气温上升损害适应性产热能力,而细颗粒物(PM2.5)和持久性有机污染物(如DDT/DDE)等环境污染物会诱导脂肪组织炎症、线粒体功能障碍和胰岛素抵抗。

📋 英文结构化总结 English Structured Summary

全文整理

EN

Background:

Obesity, characterized by excessive fat accumulation due to energy imbalance, is a global pandemic that significantly increases the risk of metabolic disorders such as type 2 diabetes mellitus (T2DM). Adipose tissue—particularly white adipose tissue (WAT) and brown adipose tissue (BAT)—plays a central role in energy storage, thermoregulation, and metabolic homeostasis. BAT, rich in uncoupling protein 1 (UCP1), promotes energy expenditure through thermogenesis and is inversely associated with obesity. Emerging evidence suggests that climate change and air pollution disrupt adipose tissue function, contributing to increased adiposity and metabolic dysfunction. Rising global temperatures impair adaptive thermogenesis, while environmental pollutants like fine particulate matter (PM2.5) and persistent organic pollutants (e.g., DDT/DDE) induce inflammation, mitochondrial dysfunction, and insulin resistance in adipose tissues.

Methods:

N/A – Review article. This paper synthesizes findings from existing literature on the interplay between climate change, air pollution, and adipose tissue biology. It examines epidemiological data, experimental studies (primarily rodent models), and mechanistic insights into how environmental stressors affect WAT and BAT function, glucose homeostasis, and metabolic health. The review also explores the impact of altered dietary patterns due to climate-related agricultural changes and evaluates potential adaptation and mitigation strategies.

Results:

Climate change contributes to obesity by reducing BAT-mediated thermogenesis due to prolonged exposure to thermoneutral or high ambient temperatures, leading to decreased energy expenditure. Air pollution, especially PM2.5, induces WAT expansion, adipocyte hypertrophy, and BAT “whitening”—a phenotypic shift toward WAT-like characteristics—accompanied by mitochondrial dysfunction and suppressed UCP1 expression. Pollutants such as DDT, DDE, and bisphenol A (BPA) impair BAT activity via aryl hydrocarbon receptor (AHR) activation and inflammatory signaling, whereas some polyfluoroalkyl substances (PFAS) show anti-obesogenic effects. Heat stress compromises thermoregulation in obese individuals, exacerbating insulin resistance and increasing T2DM risk. Additionally, climate-driven disruptions in food systems promote consumption of energy-dense processed diets, further fueling obesity.

Data Summary:

Globally, over 890 million adults are obese, with 61% of diabetic patients being obese; the obesity rate has nearly tripled since 1975. Each 1°C rise in outdoor temperature may be linked to an additional 100,000 annual diabetes cases in the U.S. Chronic PM2.5 exposure reduces mitochondrial number and size in both WAT and BAT, downregulates PGC-1α and UCP1, and increases lipogenic gene expression (e.g., ACC, DGAT2). Elevated CO₂ levels reduce protein content in staple crops like rice and wheat by 7–15%, potentially worsening nutritional quality and promoting adiposity.

Conclusions:

Climate change and air pollution significantly exacerbate adipose tissue dysfunction, obesity, and T2DM through multiple interconnected pathways: suppression of thermogenesis, induction of oxidative stress and inflammation, disruption of glucose and lipid metabolism, and promotion of unhealthy dietary shifts. The relationship between rising temperatures and reduced physical activity further amplifies metabolic risk. Addressing these challenges requires integrated public health and environmental policies aimed at reducing greenhouse gas emissions, improving air quality, and supporting sustainable food systems.

Practical Significance:

Understanding the metabolic consequences of climate change and pollution informs public health strategies to combat obesity and T2DM. Interventions such as promoting active transportation (e.g., cycling), adopting plant-based diets, implementing personal cooling during heatwaves, and minimizing air pollution exposure can simultaneously improve metabolic health and reduce environmental impact. These findings underscore the need for cross-sectoral policies that link climate action with chronic disease prevention.

📋 中文结构化总结 Chinese Structured Summary

中文

背景:

肥胖是一种以能量失衡导致脂肪过度堆积为特征的全球性流行病,显著增加了2型糖尿病(T2DM)等代谢性疾病的发病风险。脂肪组织——特别是白色脂肪组织(WAT)和棕色脂肪组织(BAT)——在能量储存、体温调节和代谢稳态中发挥着核心作用。BAT富含解偶联蛋白1(UCP1),通过产热作用促进能量消耗,与肥胖呈负相关。越来越多的证据表明,气候变化和空气污染会破坏脂肪组织功能,导致肥胖增加和代谢功能障碍。全球气温上升损害适应性产热能力,而细颗粒物(PM2.5)和持久性有机污染物(如DDT/DDE)等环境污染物会诱导脂肪组织炎症、线粒体功能障碍和胰岛素抵抗。

方法:

不适用——综述文章。本文综合了关于气候变化、空气污染与脂肪组织生物学之间相互作用的现有文献研究成果。文章审查了流行病学数据、实验研究(主要为啮齿动物模型)以及环境应激因素影响WAT和BAT功能、葡萄糖稳态和代谢健康的机制性见解。本综述还探讨了气候变化导致的农业变化所引发的饮食模式改变的影响,并评估了潜在的适应和缓解策略。

结果:

气候变化通过长期暴露于热中性或高温环境导致BAT介导的产热作用减弱,从而降低能量消耗,促进肥胖发生。空气污染,尤其是PM2.5,可诱导WAT扩张、脂肪细胞肥大和BAT"白化"——即向WAT样特征的表型转变——伴随线粒体功能障碍和UCP1表达受抑。DDT、DDE和双酚A(BPA)等污染物通过激活芳香烃受体(AHR)和炎症信号通路损害BAT活性,而部分多氟烷基物质(PFAS)则表现出抗肥胖效应。热应激损害肥胖个体的体温调节功能,加剧胰岛素抵抗并增加T2DM风险。此外,气候驱动的粮食系统紊乱促进了高能量加工食品的摄入,进一步加剧肥胖。

数据摘要:

全球有超过8.9亿成年人患有肥胖症,其中61%的糖尿病患者为肥胖人群;自1975年以来,肥胖率几乎增长了两倍。室外温度每升高1°C,美国每年可能新增约10万例糖尿病病例。长期暴露于PM2.5可减少WAT和BAT中线粒体的数量和体积,下调PGC-1α和UCP1表达,并增加脂肪生成基因(如ACC、DGAT2)的表达。大气CO₂浓度升高使水稻和小麦等主食作物的蛋白质含量降低7-15%,可能恶化营养质量并促进肥胖发生。

结论:

气候变化和空气污染通过多种相互关联的途径显著加剧脂肪组织功能障碍、肥胖和T2DM:抑制产热作用、诱导氧化应激和炎症、破坏葡萄糖和脂质代谢,以及促进不健康饮食转变。气温上升与体力活动减少之间的关系进一步放大了代谢风险。应对这些挑战需要综合性的公共卫生和环境政策,旨在减少温室气体排放、改善空气质量并支持可持续粮食系统。

实践意义:

了解气候变化和污染的代谢后果有助于制定应对肥胖和T2DM的公共卫生策略。推广主动交通方式(如骑行)、采用植物性饮食、在热浪期间实施个人降温措施以及减少空气污染暴露等干预措施,可同时改善代谢健康并减少环境影响。这些发现强调了将气候行动与慢性病预防相结合、制定跨部门政策的必要性。

📖 英文全文 English Full Text

EN

pmc Int J Mol Sci Int J Mol Sci 808 ijms ijms International Journal of Molecular Sciences 1422-0067 Multidisciplinary Digital Publishing Institute (MDPI) PMC11277516 PMC11277516.1 11277516 11277516 39063092 10.3390/ijms25147849 ijms-25-07849 1 Review Adipose Tissue Dysfunction Related to Climate Change and Air Pollution: Understanding the Metabolic Consequences https://orcid.org/0000-0002-5942-1622 Stojchevski Radoslav 1 2 3 † https://orcid.org/0000-0002-1581-6008 Chandrasekaran Preethi 4 † https://orcid.org/0000-0002-4498-7359 Hadzi-Petrushev Nikola 5 https://orcid.org/0000-0003-3475-2131 Mladenov Mitko 5 https://orcid.org/0000-0002-4479-6448 Avtanski Dimiter 1 2 3 * Palmeira Carlos Academic Editor 1 Friedman Diabetes Institute, Lenox Hill Hospital, Northwell Health, New York, NY 10003, USA; rstojchevski@northwell.edu 2 Feinstein Institutes for Medical Research, Manhasset, NY 11030, USA 3 Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY 11549, USA 4 UT Southwestern Medical Center Dallas, Dallas, TX 75390, USA; preethi.chandrasekaran@utsouthwestern.edu 5 Faculty of Natural Sciences and Mathematics, Institute of Biology, Ss. Cyril and Methodius University, 1000 Skopje, North Macedonia; nikola@pmf.ukim.mk (N.H.-P.); mitkom@pmf.ukim.mk (M.M.) * Correspondence: davtanski@northwell.edu ; Tel.: +1-(212)-434-3552 † These authors contributed equally to this work. 18 7 2024 7 2024 25 14 467552 7849 29 5 2024 12 7 2024 16 7 2024 18 07 2024 27 07 2024 28 07 2024 © 2024 by the authors. 2024 https://creativecommons.org/licenses/by/4.0/ Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( https://creativecommons.org/licenses/by/4.0/ ). Obesity, a global pandemic, poses a major threat to healthcare systems worldwide. Adipose tissue, the energy-storing organ during excessive energy intake, functions as a thermoregulator, interacting with other tissues to regulate systemic metabolism. Specifically, brown adipose tissue (BAT) is positively associated with an increased resistance to obesity, due to its thermogenic function in the presence of uncoupled protein 1 (UCP1). Recently, studies on climate change and the influence of environmental pollutants on energy homeostasis and obesity have drawn increasing attention. The reciprocal relationship between increasing adiposity and increasing temperatures results in reduced adaptive thermogenesis, decreased physical activity, and increased carbon footprint production. In addition, the impact of climate change makes obese individuals more prone to developing type 2 diabetes mellitus (T2DM). An impaired response to heat stress, compromised vasodilation, and sweating increase the risk of diabetes-related comorbidities. This comprehensive review provides information about the effects of climate change on obesity and adipose tissue, the risk of T2DM development, and insights into the environmental pollutants causing adipose tissue dysfunction and obesity. The effects of altered dietary patterns on adiposity and adaptation strategies to mitigate the detrimental effects of climate change are also discussed. climate change adiposity WAT BAT air pollution obesity adipose tissue dysfunctions This research received no external funding. pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes pmc-license-ref CC BY 1. Introduction Obesity, the condition of excessive fat accumulation, occurs when energy intake is greater than energy expenditure, resulting in an energy surplus stored in white adipose tissue (WAT). This imbalance in energy homeostasis leads to various metabolic disorders, including type 2 diabetes mellitus (T2DM). On the other hand, brown adipose tissue (BAT), characterized by brown multilocular adipocytes, stimulates thermogenesis, increasing energy expenditure to combat excessive fat accumulation in WAT, thereby emerging as a promising target for treating obesity and metabolic disorders [ 1 , 2 ]. Obesity is a significant risk factor for the development and progression of T2DM [ 3 ]. The prevalence of T2DM is further amplified by unhealthy dietary patterns, obesity, and physical inactivity [ 4 ]. As global health challenges, both obesity and T2DM are influenced by various environmental factors, including climate change and rising air pollution levels. The current literature supports the hypothesis that some environmental pollutants, such as dichlorodiphenyltrichloroethane (DDT) and its metabolite dichlordiphenylethylene (DDE), are associated with increased obesity by impairing the mass and function of BAT. DDE and DDT are persistent organic pollutants that were widely used as pesticides in the past and continue to be present in the environment due to their slow degradation [ 5 ]. Air pollutants, particularly fine particulate matter (PM2.5), induce insulin resistance (IR) due to BAT mitochondrial dysfunction [ 6 ]. BAT is stimulated by cold exposure and insulin and is inversely correlated with body mass index (BMI). In addition, alterations in thermogenic gene expression are key features of obesity and IR [ 2 ]. The link between increasing adiposity and rising temperatures leads to reduced adaptive thermogenesis, decreased physical activity, and increased carbon footprint production. Additionally, the impact of climate change makes obese individuals more prone to developing T2DM. Impaired responses to heat stress, compromised vasodilation, and sweating due to the effects of climate change increase the risk of diabetes-related comorbidities. This review aims to provide a comprehensive analysis of the effects of climate change, air pollution, and environmental factors on adipose tissue function and metabolic health. We also explore how rising temperatures and environmental pollutants affect WAT and BAT, contributing to obesity and T2DM. Additionally, we discuss potential adaptation and mitigation strategies with which to address the adverse effects of these global challenges. 2. Adipose Tissue and Metabolic Health Adipose tissue functions as a metabolic sink, playing a versatile role in regulating lipid metabolism and glucose homeostasis. Metabolic diseases, such as IR, inflammation, lipid overload, and endoplasmic reticulum (ER) stress, are closely linked to adipose tissue dysfunction. Dysfunctional adipose tissue leads to differences in adipocyte characteristics and the distribution of fat deposits in obese individuals [ 7 ]. Under surplus energy conditions, adipocytes synthesize triglycerides (TGs) from the free fatty acids (FFAs) released into circulation, in addition to utilizing the fatty acids converted from acetyl CoA within the cells by de novo lipogenesis [ 8 ]. Additionally, the size of the adipocytes increases (hypertrophy), and additional adipocytes are recruited from the pre-adipocytes (hyperplasia). During these processes, the extensive tissue remodeling and activation of inflammation that occurs subsequently lead to obesity, IR, and metabolic dysfunction [ 8 ]. In line with this, adverse metabolic consequences, such as the accumulation of visceral fat in ectopic sites, dyslipidemia, and lipodystrophy, are evident [ 9 , 10 ]. It is important to understand the role of adipose tissue in glucose homeostasis. Thermogenic adipose tissue serves as a glucose sink under adrenergic stimulation, and the expression of glucose transporter type 4 (GLUT4) participates in peripheral glucose disposal [ 11 ]. The key hormones released by adipose tissue include leptin, adiponectin, and resistin. Leptin increases energy expenditure, and its levels are correlated with adipose tissue mass. Obese states are characterized by leptin resistance, and consequently, increased leptin levels act as a compensatory mechanism [ 12 ]. On the other hand, adiponectin suppresses hepatic glucose production and enhances muscle glucose uptake [ 13 ]. Recent studies have further elucidated the mechanisms linking adipose tissue dysfunction to metabolic disorders and obesity, highlighting the roles of impaired adipogenesis, altered adipokine secretion, chronic low-grade inflammation, increased FFA levels, and ectopic lipid accumulation [ 14 , 15 ]. The balance between lipogenesis and lipolysis is disturbed in obesity due to adipose tissue inflammation and increased tumor necrosis factor alpha (TNFα) levels, which interfere with insulin signaling [ 10 , 16 ]. The ectopic lipid accumulation in insulin-responsive metabolic tissues (also known as lipotoxicity) impairs insulin signaling [ 4 ]. 2.1. WAT and Metabolic Health WAT is the main type of body fat, categorized into two key subgroups: subcutaneous WAT (sWAT), located under the skin, and visceral WAT (vWAT), found around the abdominal organs [ 7 ]. sWAT is a main depot for lipid storage [ 17 ]. It provides insulation, protection against infections, and mechanical stress relief [ 8 ]. vWAT is usually present in small amounts in healthy individuals and is highly metabolically active, releasing FFAs into the bloodstream. In obesity, excess fat accumulates in the vWAT and other ectopic sites, such as around the heart, blood vessels, digestive organs, liver, and kidneys. This leads to insulin overproduction and resistance, inflammation, and fat deposits in the arteries [ 8 , 9 ]. WAT is the primary site for energy storage, in the form of triacylglycerols, and exhibits high plasticity. Thus, WAT has the ability to expand, reduce, and remodel in response to various metabolic stimuli, such as diet, exercise, and obesity [ 18 ]. The ability of sWAT expansion is the key determinant of metabolic dysregulation in obesity [ 19 ]. When there is an energy imbalance, the physiological capacity of WAT to accommodate the excess fat is exceeded, triggering organelle stress, tissue hypoxia, the accumulation of extracellular matrix components, tissue infiltration by immune cells, mitochondrial dysfunction, and lipid droplet abnormalities [ 20 , 21 , 22 ]. Moreover, WAT functions as an important endocrine organ by secreting various endocrine factors, such as adipokines, hormones, growth, and inflammatory, which regulate metabolic processes, inflammation, and insulin sensitivity. These secretions play crucial roles in maintaining energy balance and overall metabolic health. 2.2. BAT and Metabolic Health BAT’s uniqueness lies in its expression of uncoupled protein 1 (UCP1), an inner mitochondrial membrane protein responsible for thermogenesis by uncoupling the mitochondrial proton gradient from ATP production to generate heat [ 17 ]. Another class of adipocytes, known as beige adipocytes, expresses UCP1 but utilizes UCP1-independent thermogenic mechanisms, such as Ca 2+ cycling [ 17 ]. In addition to the regulation of thermogenesis, BAT is involved in crosstalk with several peripheral tissues, such as the liver, skeletal muscle, and immune cells, to regulate systemic energy balance and glucose homeostasis [ 23 ]. It is interesting to note that BAT secretes BATokines, such as fibroblast growth factor 21 (FGF21), interleukin-6 (IL-6), growth differentiation factor 15 (GDF-15), and others [ 24 ]. Studies have revealed that human pluripotent cells derived from brown adipocytes significantly improve glucose and lipid metabolism and prevent obesity [ 25 ]. Recent studies have reported the association of human BAT with lower TG levels, blood glucose, and higher high-density lipoprotein (HDL) levels [ 26 ]. In response to acute or mild cold exposure, BAT activation maintains the thermal demands through non-shivering thermogenesis [ 27 ]. Cold acclimation increases the oxidative capacity of BAT, which correlates with a reduction in shivering thermogenesis. In addition, cold adaptation in BAT is also associated with mitochondrial remodeling and vascularization for adaptive thermogenesis and fatty oxidation through UCP1 during periods of high metabolic demands [ 28 , 29 ]. The physiological regulation of BAT is mediated mainly via beta-3-adrenergic receptors present in brown adipocytes [ 30 ]. Additionally, BAT has a critical role in glucose metabolism. The translocation of GLUT1 and GLUT4 to the plasma membrane of brown adipocytes is induced by the stimulation of adrenergic signaling by cold exposure [ 11 ]. The uptake of glucose by BAT is also regulated by insulin signaling via the phosphatidylinositol 3-kinase (PI3K)–phosphoinositide-dependent kinase-1 (PDK1)–protein kinase B (PKB/Akt) signaling pathway, promoting the translocation of GLUT4 to the plasma membrane [ 11 ]. The major strategy for treating obesity and metabolic disorders is the manipulation of WAT to the human-like phenotype with increased thermogenic capacity, through a process called “adipocyte browning” [ 31 ]. 3. Effects of Climate Change on Adipose Tissue Climate change significantly impacts adipose tissue function and metabolism, exacerbating the prevalence of obesity and metabolic disorders. The rising temperatures associated with global warming impair BAT thermogenesis, reducing energy expenditure and increasing adiposity [ 32 ]. Furthermore, climate change-related factors, such as air pollution and altered dietary patterns, disrupt adipose tissue homeostasis, increasing the risk of metabolic dysfunction [ 33 ]. The rise in temperatures also challenges thermoregulation in endothermic species, placing a burden on compensatory mechanisms and raising the risk of heat stress [ 34 ]. These environmental stressors, along with extreme weather events and deforestation, further aggravate the issue by influencing nutrition, physical activity levels, and overall metabolic health [ 35 ]. The role of adipose tissue in maintaining energy homeostasis is essential to the pathophysiology of metabolic disorders. Several reactions, such as vasoconstriction and piloerection, are known to maintain the core body temperature in mammals in response to thermal challenges [ 36 ]. Shivering thermogenesis is an acute response to thermal stress, presenting as a continual contraction and relaxation of muscles. In contrast, non-shivering thermogenesis occurs in BAT, generating heat during chronic cold exposure, which is a long-term strategy to respond to cold challenges [ 37 , 38 ]. It is important to note that the metabolic rate increases when the temperature is below the thermoneutral zone, due to the increased energy required to maintain body temperature ( Figure 1 a). However, when the temperature exceeds the thermoneutral zone, the body’s cooling mechanisms activate energy expenditure [ 39 ] ( Figure 1 b). In addition to BAT, sWAT and inguinal WAT (iWAT) undergo morphological changes at different temperatures. For example, in cold environments, sWAT and iWAT undergo a browning process [ 40 , 41 ]. Exposure to cold temperatures induces altered polarization of the macrophages in BAT. These polarized macrophages contribute to thermogenesis by producing catecholamines that directly activate β-adrenergic signaling in adipocytes [ 42 ] ( Figure 1 c). Briefly, cold exposure stimulates an increase in the oxidative metabolism rates of brown and beige adipocytes, resulting in an increased uptake of glucose and free fatty acids ( Figure 1 d). 3.1. Climate Change and Obesity It is alarming that obesity affects more than 890 million adults (or one in eight people) globally [ 43 ]. Notably, 61% of diabetic patients are obese. The global obesity rate has nearly tripled since 1975 [ 44 ]. Global warming is caused by increased greenhouse gas (GHG) emissions, such as CO 2 , methane, nitrous oxide, ozone, and fluorinated gases such as chlorofluorocarbons (CFCs) and hydrofluorocarbons (HFCs) [ 45 ]. The National Longitudinal Study of Adolescent to Adult Health (Add Health) demonstrated that the atmospheric temperature correlates with a slight increase in weight [ 46 ]. The increase in oxidative metabolism due to greater metabolic demands and increased food intake may result from high GHG emissions [ 47 ] ( Figure 2 a). Obesity stems from many factors, such as high-calorie intake, physical inactivity, and decreased energy dissipation. Impaired thermogenesis is promoted by the reduced expression of the thermogenic genes encoding uncoupling proteins, thyroid hormone receptors, and β-adrenergic receptors, due to chemicals that disrupt hormone metabolism, which increase body weight [ 48 ]. Several studies have found that thermogenesis, a process in which brown or beige adipocytes contribute to increased energy expenditure, varies among different populations [ 49 , 50 , 51 ], and some of these variations may be attributed to the environment [ 52 , 53 ]. Increased time spent in the thermal neutral zone can lead to a loss of BAT and decreased thermogenic activity [ 54 ] ( Figure 2 b). It is established that thermogenesis plateaus above moderate physical activity levels. Regarding diet-induced thermogenesis, the energy released in the form of heat varies depending on the macronutrient composition of the food consumed. The thermic effect is lowest for fat (0–3%), followed by that for carbohydrates (5–10%), and is highest for protein (20–30%) [ 55 , 56 ] ( Figure 2 c). The variability in diet-induced thermogenesis can be attributed to factors such as sex, age, body composition, and hormonal status [ 57 ]. Exposure to ambient temperature plays an important role in BAT activity. The increased time spent in the thermal comfort zone decreases energy expenditure and has potential obesogenic consequences. At high temperatures, the neuroendocrine mechanism reduces food intake and metabolism, leading to decreased thyroid activity and testosterone and cortisol levels [ 58 ]. In contrast, low temperatures increase adrenal steroid hormone levels and the activity of the pituitary and thyroid glands. A rise in temperature negatively impacts agriculture, resulting in scarce fresh produce. Increased GHG emissions indirectly contribute to the higher production of processed foods due to multiple factors, such as the reduced availability and increased price of fresh food. The increased consumption of processed foods, characterized by their high levels of salt, sugar, and fat, leads to various health issues, including obesity and metabolic disorders [ 33 ] ( Figure 2 d). In addition, extreme temperatures negatively affect the level of physical activity, leading to a sedentary lifestyle [ 33 ] ( Figure 2 e). 3.2. Climate Change and T2DM Upon exposure to heat, the human body responds with peripheral vasodilation, increased sweat secretion to dissipate energy, and the redistribution of blood flow to the skin. These responses cause heat loss, aiming to maintain optimal body temperature [ 59 ] ( Figure 3 a). Elevated blood flow to the skin may result in dehydration and the impairment of insulin signaling and glucose disposal via the inhibition of cellular insulin action and a decrease in blood flow to insulin-sensitive tissues. Furthermore, dehydration promotes IR by disrupting downstream signaling pathways, such as PI3K and hyperosmotic inhibition of PKB activation. Strikingly, increased vasopressin levels due to dehydration stimulate glucose production in the liver and promote IR in the liver, adipose tissue, and pancreas [ 60 ] ( Figure 3 b). In T2DM, high temperatures may also disrupt thermoregulation by impairing the orthostatic response [ 32 ]. Blauw et al. [ 61 ] estimated that each degree of C increase in the outdoor temperature may be associated with 100,000 new diabetes cases annually in the United States ( Figure 3 c). Several studies have reported that air pollution increases IR and its associated complications [ 62 , 63 , 64 , 65 ]. Air pollutants, such as ozone and fine particulate matter (PM), can cause diabetic complications [ 66 ]. Fine particulate matter up to 2.5 μm (PM2.5) is a mixture of organic and inorganic chemicals generated from human and natural sources. It consists of carbonaceous nuclei that absorb polycyclic aromatic hydrocarbons and endotoxic metals from the atmosphere [ 67 , 68 ]. PM2.5 is known to increase the risk of T2DM and its associated cardiovascular diseases (CVD) [ 69 ] ( Figure 3 d). 4. Environmental Factors Affecting Adipose Tissue Metabolism Adipose tissue undergoes hyperplasia and hypertrophy in response to energy overload and temperature changes. Perinatal exposure to endocrine disruptors, such as DDT, may impair BAT thermogenesis and increase the risk of metabolic syndrome [ 70 ]. In addition, air pollutants increase the risk of IR due to BAT mitochondrial dysfunction. The mechanism linking thermogenesis to the risk of IR involves the activation of peroxisome proliferator-activated receptor-gamma co-activator-1-alpha (PGC-1α), a master regulator of energy metabolism [ 70 ]. Furthermore, the effects of DDT and DDE on BAT may be mediated by the aryl hydrocarbon receptor (AHR), a physiological carbon regulator of energy metabolism. AHR activation is increased by pro-inflammatory cytokines [ 71 ]. In short, DDT and its metabolite DDE induce nuclear factor-kappa B (NF-κB) activation and the production of pro-inflammatory cytokines, which mediate the upregulation of the AHR [ 71 ]. 4.1. Air Pollutants and BAT Long-term exposure to PM2.5 has been shown to induce inflammation and decrease BAT weight, mitochondrial size in BAT, and mitochondrial number in WAT, changes associated with a process known as BAT “whitening” [ 68 ]. Interestingly, homeobox protein C9 (HOXC9) and insulin-like growth factor binding protein 3 (IGFBP3) genes, characteristic of WAT, are upregulated in BAT, supporting the transformation of brown adipocytes to the WAT phenotype [ 72 ]. Zhang et al. [ 6 ] suggested that PM2.5 might impact BAT development through TNFα-mediated apoptosis and inflammation. BAT inflammation is associated with impaired insulin signaling, as evidenced by the decreased Ser437 phosphorylation of AKT in BAT [ 68 ]. Additionally, long-term exposure to PM2.5 induces low-grade inflammation in the hypothalamus, indirectly causing BAT dysfunction. Other pollutants, such as mono-2-ethylhexyl phthalate (MEHP), promote adipocyte differentiation and induce obesity in mice [ 73 ]. A study by Farrugia et al. [ 74 ] suggested a correlation between bisphenol A (BPA) and obesity, diabetes, and metabolic disorders. In contrast, polyfluoroalkyl substances (PFAS), such as perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), have anti-obesogenic effects, increasing the rate of oxidative capacity in brown fat mitochondria via UCP1 upregulation [ 75 ]. DDT and DDE impair BAT activity through multiple mechanisms, including reducing substrate transport and utilization, downregulating the expression of the genes involved in thermogenesis, inhibiting the deiodination of thyroxine (T4) to triiodothyronine (T3), and inducing IR and inflammatory pathways in BAT [ 70 ]. In contrast, PFOA and PFOS increase mitochondrial oxidation via UCP1 upregulation in BAT, thereby decreasing food intake and body weight. 4.2. Temperature-Related Adaptations of BAT Function and Metabolism Changes in temperature alter the physiological and molecular aspects of adipose tissue to adjust to a new tissue homeostasis. Studies on mice have revealed that differences in metabolic rates have been observed due to thermal challenges. A gradual decrease in temperature from 30 °C to mild cold temperature (16–20 °C) to severe cold (5 °C) temperature causes a gradual increase in oxygen consumption [ 76 ]. Thus, when the temperature is decreased, the rate of metabolism increases as more energy is required to maintain body temperature. On the other hand, energy expenditure is stimulated when the ambient temperature exceeds the thermoneutral zone and body-cooling mechanisms are activated [ 77 ]. One study demonstrated the effects that housing ob / ob mice at 14 °C, 22 °C, and 30 °C had on their core temperature and energy expenditure. In this case, the hypothermic phenotype of the ob / ob mice was partially rescued by leptin administration associated with decreased thermal conductance, proving the physiological effects of leptin in maintaining core body temperature under sub-thermoneutral conditions [ 78 ]. The ambient temperature plays a crucial role in defining the metabolic phenotypes of mice. For example, nude mice exhibit reduced heat insulation and might activate compensatory thermogenic programs, such as BAT and beige adipocyte-mediated non-shivering thermogenesis (NST), leading to increased energy expenditure [ 79 ]. It is well known that BAT activity improves obesity-induced metabolic dysfunction. However, a lack of brown adipocytes increases body weight, IR, and adipose tissue inflammation [ 80 ]. BAT has multilocular brown adipocytes at room temperature, whereas in the thermoneutral (TN) zone, it has unilocular brown adipocytes. In addition, at cold temperatures, iWAT consists of multilocular adipocytes, indicating a browning event, which completely disappears in the TN zone [ 40 ]. Furthermore, in the TN zone, whitened BAT exhibits decreased mitochondrial density and gene and protein expression [ 81 ]. Exposure to cold induces the alternative polarization of the macrophages in BAT and beige adipose tissue (BeAT), which induces thermogenesis by producing catecholamines and directly activating β-adrenergic signaling in adipocytes [ 82 ]. Another important feature is the alteration of immune cell composition; being in the TN zone systemically causes an accumulation of lymphocyte antigen 6 complex, locus G (LYG6) + monocytes in bone marrow. Additionally, there is an increase in the TNFα and IL-6 levels in the serum of mice [ 83 ]. Conversely, cold exposure results in fewer activated monocytes and reduced T cell expression in autoimmunity [ 82 ]. Intermittent cold exposure (ICE) (exposing the body to low temperatures for short periods) is known to increase subcutaneous WAT and has variable effects on visceral WAT. ICE promotes weight loss maintenance and attenuates the positive energy balance during relapse by increasing energy expenditure in mice [ 84 ]. Numerous studies have demonstrated that ICE increases BAT activation and reduces weight [ 85 ]. ICE induces systemic responses to defend the core body temperature. For example, increased glucagon due to ICE acts as a browning stimulus via the activation of FGF21 secretion. The high expression of UCP1, high rates of substrate turnover, and abundant mitochondria are other alterations in the network of crosstalk underlying the physiological responses to ICE [ 86 ]. In BAT, the induction of UCP1 and peroxisome proliferator-activated receptor-gamma (PPARγ) expression increases the fat utilization capacity via the increased expression of lipoprotein lipase (LPL) [ 87 ]. Furthermore, beige adipocytes, which are highly responsive to cold, have increased sensitivity to irisin secreted by muscles [ 88 ]. It is essential to understand the effects of cold exposure on the secretory function of adipose tissue, particularly the modulatory role of adipokines in blood glucose and insulin sensitivity; however, direct evidence linking ICE and adipokine modulation is limited. Wang et al. [ 89 ] reported that the combination of ICE and exercise in rats reduced IR and blood glucose levels. In addition, adipose triglyceride lipase (ATGL) and LPL activity in inguinal adipose tissue were shown to increase in response to ICE. Moreover, ICE enhances the capacity of skeletal muscles to oxidize FFAs via PGC1α and p38 MAPK upregulation [ 89 ]. As much of the research is centered on rodent models, further research is needed on the effects of ICE on humans. 4.3. Air Pollutants and WAT Dysfunction Chronic exposure to PM2.5 is associated with WAT expansion and increased adiposity [ 90 ]. In addition to stimulating adipogenesis, PM2.5 also decreases catecholamine-induced lipolysis. Additionally, PM2.5 exposure is associated with altered thyroid function and decreased T3 and T4 plasma levels [ 67 , 91 ]. In skeletal muscles, PM2.5 exposure inhibits NO-dependent microvessel dilation and decreases mitochondrial oxidative capacity [ 67 ]. Results from multiple rodent studies have suggested that exposure to PM2.5 induces adipocyte hypertrophy and WAT expansion. Notably, PM2.5 directly oxidizes organic molecules and stimulates reactive oxygen species (ROS) production, interfering with the mitochondrial respiratory chain in cells [ 68 ]. The evidence suggests that long-term exposure to PM2.5 in rodents increases the expression of lipogenic genes, such as those encoding acetyl-CoA carboxylase (ACC) and diacylglycerol O-acyltransferase 2 (DGAT2), with an increase in PPARα and cAMP response element-binding protein alpha (CREB-α) [ 92 , 93 ]. Importantly, exposure to PM2.5 leads to hypothalamic inflammation associated with leptin resistance, decreased energy expenditure, and WAT accumulation [ 94 ]. Additionally, it is associated with increased gut permeability, causing the migration of bacterial LPS and the release of pro-inflammatory molecules, stimulating WAT inflammation and adipogenesis. Moreover, chronic PM2.5 exposure causes a significant reduction in the mitochondrial number and size in WAT and BAT, suppressing PCG-1α and UCP1, and leading to impaired lipid metabolism, increased oxidative stress, mitochondrial dysfunction, and TG storage in white adipocytes [ 95 , 96 ]. 4.4. Association between Climate Change, Air Pollution, and Altered Dietary Patterns Unhealthy dietary habits, such as a high intake of fried and sugar-rich foods and a decreased consumption of red meat, fruits, and vegetables, contribute to central and global adiposity. Furthermore, these dietary habits are associated with sedentary behavior in adults [ 97 ]. A high intake of white bread is also associated with central and global adiposity in adults [ 98 ]. Studies have shown that food availability, access, and utilization can largely influence dietary patterns and lead to the consumption of high-calorie or processed foods. This also leads to an inadequate consumption of essential nutrients, such as proteins, vitamins, and minerals, contributing to dyslipidemia and increased central adiposity [ 99 , 100 ]. Climate change also affects soil fertility, rain patterns, crop yields, food production, and nutrient bioavailability [ 101 ]. It is important to note that there is a reciprocal and cyclical association between food production and climate change. Increased fertilizer use and deforestation lead to increased GHG emissions and climate change, subsequently decreasing food production [ 102 ]. Weather events, such as drought, flooding, and heat waves, correlate with decreased rain patterns, reduced soil fertility, and acid rain due to increased fertilizer usage [ 103 ]. Additionally, climate change alters supply chains, transportation, yield, biomass food composition, the quality of nutrition, and food prices. All these effects collectively increase the consumption of processed foods and high-calorie diets, thus elevating the incidence of abdominal adiposity [ 104 ]. Air pollution can also influence dietary patterns by affecting food production, quality, and consumption. Exposure to air pollutants, such as PM2.5 and nitrogen oxides (NO x ), can reduce crop yields and nutrient content, potentially leading to the increased consumption of processed and energy-dense foods [ 105 ]. Additionally, air pollution has been associated with increased oxidative stress and inflammation, which may alter appetite regulation and food preferences, promoting the consumption of high-calorie and high-fat foods [ 106 ]. These changes in dietary patterns can further exacerbate the risk of obesity and metabolic disorders. Moreover, increased CO 2 concentrations in the atmosphere result in decreased plant protein content and micronutrients, such as calcium, iron, and zinc. For example, C3 grains and tubers, such as rice, wheat, barley, and potatoes, have experienced a 7–15% decrease in protein content [ 107 ]. Thus, climate change and air pollution have a clear nutritional effect that can reduce or worsen food availability and dietary diversity. 5. Climate Change Adaptation and Mitigation Strategies Climate change and air pollution are global threats that accelerate antimicrobial resistance, food and airborne diseases, and metabolic disorders. Climate change reduces crop yields and their micronutrient content, disrupting the food supply chain and increasing obesity rates [ 108 ]. Minimizing GHG emissions will help to reduce climate change impacts to a large extent [ 109 ]. The use of fossil fuels increases GHG emissions, obesity, and metabolic dysfunction. Increased physical activity, such as walking or biking, can decrease the prevalence of obesity [ 110 ]. A sustainable diet with a low microenvironmental impact is safe and could help reduce obesity and its dire consequences. Reducing meat consumption can significantly decrease GHG generation, thus indirectly impacting crop growth [ 111 ]. Incorporating plant-based proteins, such as soy, legumes, and nuts, into the diet has been suggested as a potential strategy with which to mitigate the effects of climate change and pollution-induced obesity [ 112 ]. These protein sources have a lower environmental impact compared to animal-based proteins, and their consumption has been associated with better weight management and a reduced risk of obesity-related comorbidities. Furthermore, promoting active transportation, such as walking and cycling, can contribute to a decrease in air pollution, particularly in the form of PM2.5, which has been linked to an increased risk of obesity [ 113 ]. Given the multiple threats posed by factors, such as heat, pollution, and extreme weather events, that exacerbate diabetes, the implementation of various mitigation strategies and individual adaptation measures is crucial. These strategies may include personal cooling techniques during periods of extreme heat, efforts to minimize the effects of air pollution through lifestyle modifications that reduce GHG emissions, and limiting outdoor activities or wearing face masks to minimize exposure to high levels of air pollution [ 114 , 115 ]. Additionally, BAT activation in cold environments has been shown to increase lipid oxidation and glucose uptake in skeletal muscle, leading to improved insulin sensitivity [ 32 ]. This highlights the potential benefits of cold exposure as a therapeutic approach to managing diabetes. Moreover, shifting from vehicle transportation to cycling would increase physical activity levels and contribute to a reduction in GHG emissions, which might ultimately lower the risk of developing T2DM [ 116 ]. Promoting active transportation and encouraging the adoption of low-carbon transportation models could have significant health benefits while simultaneously addressing environmental concerns. 6. Conclusions This review highlights the significant impact of climate change and air pollution on adipose tissue dysfunction, obesity, and metabolic health. The rising temperatures associated with global warming can impair BAT thermogenesis and adaptive energy expenditure, contributing to increased adiposity. Air pollution, particularly exposure to PM2.5, can induce WAT inflammation, oxidative stress, and mitochondrial dysfunction, exacerbating the risk of IR and metabolic disorders. Furthermore, climate change and air pollution can alter dietary patterns, promoting the consumption of energy-dense and processed foods, further contributing to the obesity epidemic. The bidirectional relationship between obesity and climate change is evident in the current literature. The impact of climate change, particularly the increase in ambient temperatures, is expected to contribute to higher rates of obesity and T2DM, partially due to reduced physical activity levels. As the global climate continues to change, developing and implementing individual and collective strategies will be crucial for minimizing the adverse effects on public health. Reducing the adverse effects of climate change and air pollution on metabolic health requires the implementation of policies and interventions to reduce GHG emissions, improve air quality, and promote healthy dietary habits. These may include promoting renewable energy sources, applying energy-efficient technologies, and encouraging sustainable land-use practices. Furthermore, public health initiatives that focus on promoting healthy eating habits and reducing the intake of processed foods could contribute to individual health and environmental sustainability. Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. Author Contributions Conceptualization, D.A.; investigation, P.C., R.S. and D.A.; writing—original draft preparation, P.C., R.S. and D.A.; writing—review and editing, R.S., N.H.-P., M.M. and D.A.; visualization, D.A. All authors have read and agreed to the published version of the manuscript. Data Availability Statement No new data were created or analyzed in this study. Data sharing is not applicable to this article. Conflicts of Interest The authors declare no conflicts of interest. Abbreviations ACC Acetyl-CoA carboxylase AHR Aryl hydrocarbon receptor ATGL Adipose triglyceride lipase BAT Brown adipose tissue BeAT Beige adipose tissue BMI Body mass index BPA Bisphenol A CFC Chlorofluorocarbon CREB-α cAMP response element-binding protein alpha CVD Cardiovascular diseases DDE Dichlordiphenylethylene DDT Dichlorodiphenyltrichloroethane DGAT2 Diacylglycerol O-acyltransferase 2 ER Endoplasmic reticulum FFA Free fatty acid FGF21 Fibroblast growth factor 21 GDF-15 Growth differentiation factor 15 GHG Greenhouse gas GLUT1 Glucose transporter type 1 GLUT4 Glucose transporter type 4 HFC Hydrofluorocarbons HDL High-density lipoprotein HOXC9 Homeobox protein C9 ICE Intermittent cold exposure IGFBP3 Insulin-like growth factor binding protein 3 IL-6 Interleukin-6 IR Insulin resistance iWAT Inguinal WAT LPL Lipoprotein lipase LYG6 Lymphocyte antigen 6 complex, locus G MEHP Mono-2-ethylhexyl phthalate NF-κB Nuclear factor-kappa B NOx Nitrogen oxides NST Non-shivering thermogenesis PDK1 Phosphoinositide-dependent kinase-1 PGC-1α Peroxisome proliferator-activated receptor-gamma co-activator-1-alpha PFAS Polyfluoroalkyl substances PFOA Perfluorooctanoic acid PFOS Perfluorooctane sulfonate PI3K Phosphatidylinositol 3-kinase PKB Protein kinase B (or Akt) PM Particulate matter PM2.5 Particulate matter up to 2.5 μm PPARα Peroxisome proliferator-activated receptor-alpha PPARγ Peroxisome proliferator-activated receptor-gamma ROS Reactive oxygen species sWAT Subcutaneous WAT T2DM Type 2 diabetes mellitus T3 Triiodothyronine T4 Thyroxine TG Triglyceride TN Thermoneutral TNFα Tumor necrosis factor alpha UCP1 Uncoupled protein 1 vWAT Visceral WAT WAT White adipose tissue References 1.

Carpentier A.C.

Blondin D.P.

Virtanen K.A.

Richard D.

Haman F.

Turcotte É.E.

Brown Adipose Tissue Energy Metabolism in Humans Front. Endocrinol. 2018 9 447 10.3389/fendo.2018.00447 30131768 PMC6090055 2.

Jackson E.

Shoemaker R.

Larian N.

Cassis L.

Adipose Tissue as a Site of Toxin Accumulation Comprehensive Physiology Wiley Hoboken, NJ, USA 2017 1085 1135 10.1002/cphy.c160038 PMC6101675 28915320 3.

Leitner D.R.

Frühbeck G.

Yumuk V.

Schindler K.

Micic D.

Woodward E.

Toplak H.

Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies—EASO Can Lead the Way Obes. Facts 2017 10 483 492 10.1159/000480525 29020674 PMC5741209 4.

Klein S.

Gastaldelli A.

Yki-Järvinen H.

Scherer P.E.

Why does obesity cause diabetes? Cell Metab. 2022 34 11 20 10.1016/j.cmet.2021.12.012 34986330 PMC8740746 5.

Eskenazi B.

Chevrier J.

Rosas L.G.

Anderson H.A.

Bornman M.S.

Bouwman H.

Chen A.

Cohn B.A. de Jager C.

Henshel D.S.

The Pine River Statement: Human Health Consequences of DDT Use Environ. Health Perspect. 2009 117 1359 1367 10.1289/ehp.11748 19750098 PMC2737010 6.

Zhang G.

Sun Q.

Liu C.

Influencing Factors of Thermogenic Adipose Tissue Activity Front. Physiol. 2016 7 29 10.3389/fphys.2016.00029 26903879 PMC4742553 7.

Cohen P.

Kajimura S.

The cellular and functional complexity of thermogenic fat Nat. Rev. Mol. Cell Biol. 2021 22 393 409 10.1038/s41580-021-00350-0 33758402 PMC8159882 8.

Luo L.

Liu M.

Adipose tissue in control of metabolism J. Endocrinol. 2016 231 R77 R99 10.1530/JOE-16-0211 27935822 PMC7928204 9.

Harvey I.

Boudreau A.

Stephens J.M.

Adipose tissue in health and disease Open Biol. 2020 10 200291 10.1098/rsob.200291 33292104 PMC7776562 10.

Zhang T.

Chen J.

Tang X.

Luo Q.

Xu D.

Yu B.

Interaction between adipocytes and high-density lipoprotein:new insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis Lipids Health Dis. 2019 18 223 10.1186/s12944-019-1170-9 31842884 PMC6913018 11.

Chadt A.

Al-Hasani H.

Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease Pflug. Arch. 2020 472 1273 1298 10.1007/s00424-020-02417-x PMC7462924 32591906 12.

Zhao S.

Li N.

Zhu Y.

Straub L.

Zhang Z.

Wang M.-Y.

Zhu Q.

Kusminski C.M.

Elmquist J.K.

Scherer P.E.

Partial leptin deficiency confers resistance to diet-induced obesity in mice Mol. Metab. 2020 37 100995 10.1016/j.molmet.2020.100995 32289482 PMC7229277 13.

Fang H.

Judd R.L.

Adiponectin Regulation and Function Comprehensive Physiology Wiley Hoboken, NJ, USA 2018 1031 1063 10.1002/cphy.c170046 29978896 14. de Lange P.

Lombardi A.

Silvestri E.

Cioffi F.

Giacco A.

Iervolino S.

Petito G.

Senese R.

Lanni A.

Moreno M.

Physiological Approaches Targeting Cellular and Mitochondrial Pathways Underlying Adipose Organ Senescence Int. J. Mol. Sci. 2023 24 11676 10.3390/ijms241411676 37511435 PMC10380998 15.

Goossens G.H.

Blaak E.E.

Adipose tissue dysfunction and impaired metabolic health in human obesity: A matter of oxygen? Front. Endocrinol. 2015 6 55 10.3389/fendo.2015.00055 25964776 PMC4408910 16.

Morigny P.

Houssier M.

Mouisel E.

Langin D.

Adipocyte lipolysis and insulin resistance Biochimie 2016 125 259 266 10.1016/j.biochi.2015.10.024 26542285 17.

Chouchani E.T.

Kazak L.

Spiegelman B.M.

New Advances in Adaptive Thermogenesis: UCP1 and Beyond Cell Metab. 2019 29 27 37 10.1016/j.cmet.2018.11.002 30503034 18.

Cypess A.M.

Reassessing Human Adipose Tissue N. Engl. J. Med. 2022 386 768 779 10.1056/NEJMra2032804 35196429 19.

White U.

Adipose tissue expansion in obesity, health, and disease Front. Cell Dev. Biol. 2023 11 1188844 10.3389/fcell.2023.1188844 37181756 PMC10169629 20.

Giroud M.

Jodeleit H.

Prentice K.J.

Bartelt A.

Adipocyte function and the development of cardiometabolic disease J. Physiol. 2022 600 1189 1208 10.1113/JP281979 34555180 21.

White U.A.

Fitch M.D.

Beyl R.A.

Hellerstein M.K.

Ravussin E.

Association of In Vivo Adipose Tissue Cellular Kinetics With Markers of Metabolic Health in Humans J. Clin. Endocrinol. Metab. 2017 102 2171 2178 10.1210/jc.2016-4000 28323935 PMC5505198 22.

Longo M.

Zatterale F.

Naderi J.

Parrillo L.

Formisano P.

Raciti G.A.

Beguinot F.

Miele C.

Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications Int. J. Mol. Sci. 2019 20 2358 10.3390/ijms20092358 31085992 PMC6539070 23.

Rodríguez A.

Becerril S.

Ezquerro S.

Méndez-Giménez L.

Frühbeck G.

Crosstalk between adipokines and myokines in fat browning Acta Physiol. 2017 219 362 381 10.1111/apha.12686 27040995 24.

Oka M.

Kobayashi N.

Matsumura K.

Nishio M.

Nakano K.

Okamura T.

Okochi H.

Minamisawa T.

Shiba K.

Saeki K.

New Role for Growth/Differentiation Factor 15 in the Survival of Transplanted Brown Adipose Tissues in Cooperation with Interleukin-6 Cells 2020 9 1365 10.3390/cells9061365 32492819 PMC7349565 25.

Stanford K.I.

Middelbeek R.J.W.

Townsend K.L.

An D.

Nygaard E.B.

Hitchcox K.M.

Markan K.R.

Nakano K.

Hirshman M.F.

Tseng Y.-H.

Brown adipose tissue regulates glucose homeostasis and insulin sensitivity J. Clin. Investig. 2013 123 215 223 10.1172/JCI62308 23221344 PMC3533266 26.

Becher T.

Palanisamy S.

Kramer D.J.

Eljalby M.

Marx S.J.

Wibmer A.G.

Butler S.D.

Jiang C.S.

Vaughan R.

Schöder H.

Brown adipose tissue is associated with cardiometabolic health Nat. Med. 2021 27 58 65 10.1038/s41591-020-1126-7 33398160 PMC8461455 27.

Haman F.

Mantha O.L.

Cheung S.S.

DuCharme M.B.

Taber M.

Blondin D.P.

McGarr G.W.

Hartley G.L.

Hynes Z.

Basset F.A.

Oxidative fuel selection and shivering thermogenesis during a 12- and 24-h cold-survival simulation J. Appl. Physiol. 2016 120 640 648 10.1152/japplphysiol.00540.2015 26718783 28.

Bal N.C.

Maurya S.K.

Pani S.

Sethy C.

Banerjee A.

Das S.

Patnaik S.

Kundu C.N.

Mild cold induced thermogenesis: Are BAT and skeletal muscle synergistic partners? Biosci. Rep. 2017 37 BSR20171087 10.1042/BSR20171087 28831023 PMC5617911 29.

Suchacki K.J.

Stimson R.H.

Nutritional Regulation of Human Brown Adipose Tissue Nutrients 2021 13 1748 10.3390/nu13061748 34063868 PMC8224032 30.

Cypess A.M.

Weiner L.S.

Roberts-Toler C.

Franquet Elía E.

Kessler S.H.

Kahn P.A.

English J.

Chatman K.

Trauger S.A.

Doria A.

Activation of human brown adipose tissue by a β3-adrenergic receptor agonist Cell Metab. 2015 21 33 38 10.1016/j.cmet.2014.12.009 25565203 PMC4298351 31.

Warner A.

Mittag J.

Breaking BAT: Can browning create a better white? J. Endocrinol. 2016 228 R19 R29 10.1530/JOE-15-0408 26450134 32.

Symonds M.E.

Farhat G.

Aldiss P.

Pope M.

Budge H.

Brown adipose tissue and glucose homeostasis—The link between climate change and the global rise in obesity and diabetes Adipocyte 2019 8 46 50 10.1080/21623945.2018.1551689 30463471 PMC6768202 33.

An R.

Ji M.

Zhang S.

Global warming and obesity: A systematic review Obes. Rev. 2018 19 150 163 10.1111/obr.12624 28977817 34.

Lim C.L.

Fundamental Concepts of Human Thermoregulation and Adaptation to Heat: A Review in the Context of Global Warming Int. J. Environ. Res. Public Health 2020 17 7795 10.3390/ijerph17217795 33114437 PMC7662600 35.

Annesi-Maesano I.

United Nations Climate Change Conferences: COP21 a lost opportunity for asthma and allergies and preparing for COP22 J. Allergy Clin. Immunol. 2016 138 57 58 10.1016/j.jaci.2016.02.043 27373326 36.

Bastías-Pérez M.

Zagmutt S.

Soler-Vázquez M.C.

Serra D.

Mera P.

Herrero L.

Impact of Adaptive Thermogenesis in Mice on the Treatment of Obesity Cells 2020 9 316 10.3390/cells9020316 32012991 PMC7072509 37.

Bal N.C.

Periasamy M.

Uncoupling of sarcoendoplasmic reticulum calcium ATPase pump activity by sarcolipin as the basis for muscle non-shivering thermogenesis Philos. Trans. R. Soc. B Biol. Sci. 2020 375 20190135 10.1098/rstb.2019.0135 31928193 PMC7017432 38. van der Lans A.A.J.J.

Hoeks J.

Brans B.

Vijgen G.H.E.J.

Visser M.G.W.

Vosselman M.J.

Hansen J.

Jörgensen J.A.

Wu J.

Mottaghy F.M.

Cold acclimation recruits human brown fat and increases nonshivering thermogenesis J. Clin. Investig. 2013 123 3395 3403 10.1172/JCI68993 23867626 PMC3726172 39.

Machado S.A.

Pasquarelli-do-Nascimento G. da Silva D.S.

Farias G.R. de Oliveira Santos I.

Baptista L.B.

Magalhães K.G.

Browning of the white adipose tissue regulation: New insights into nutritional and metabolic relevance in health and diseases Nutr. Metab. 2022 19 61 10.1186/s12986-022-00694-0 36068578 PMC9446768 40. de Jong J.M.A.

Sun W.

Pires N.D.

Frontini A.

Balaz M.

Jespersen N.Z.

Feizi A.

Petrovic K.

Fischer A.W.

Bokhari M.H.

Human brown adipose tissue is phenocopied by classical brown adipose tissue in physiologically humanized mice Nat. Metab. 2019 1 830 843 10.1038/s42255-019-0101-4 32694768 41.

Bargut T.C.L.

Souza-Mello V.

Aguila M.B.

Mandarim-de-Lacerda C.A.

Browning of white adipose tissue: Lessons from experimental models Horm. Mol. Biol. Clin. Investig. 2017 31 20160051 10.1515/hmbci-2016-0051 28099124 42.

Pirzgalska R.M.

Seixas E.

Seidman J.S.

Link V.M.

Sánchez N.M.

Mahú I.

Mendes R.

Gres V.

Kubasova N.

Morris I.

Sympathetic neuron–associated macrophages contribute to obesity by importing and metabolizing norepinephrine Nat. Med. 2017 23 1309 1318 10.1038/nm.4422 29035364 PMC7104364 43.

World Health Organization Obesity and Overweight 2024 Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (accessed on 11 July 2024) 44.

Ampofo A.G.

Boateng E.B.

Beyond 2020: Modelling obesity and diabetes prevalence Diabetes Res. Clin. Pract. 2020 167 108362 10.1016/j.diabres.2020.108362 32758618 45.

Tan X.

Liu Y.

Dong H.

Xiao Y.

Zhao Z.

The health consequences of greenhouse gas emissions: A potential pathway Environ. Geochem. Health 2022 44 2955 2974 10.1007/s10653-021-01142-3 34993736 46.

Kanazawa S.

Does global warming contribute to the obesity epidemic? Environ. Res. 2020 182 108962 10.1016/j.envres.2019.108962 31862545 47.

Magkos F.

Tetens I.

Bügel S.G.

Felby C.

Schacht S.R.

Hill J.O.

Ravussin E.

Astrup A.

The Environmental Foodprint of Obesity Obesity 2020 28 73 79 10.1002/oby.22657 31858737 48. da Silva M.M.

Gonçalves C.F.L.

Miranda-Alves L.

Fortunato R.S.

Carvalho D.P.

Ferreira A.C.F.

Inhibition of Type 1 Iodothyronine Deiodinase by Bisphenol A Horm. Metab. Res. 2019 51 671 677 10.1055/a-0919-3879 31174228 49.

Bakker L.E.H.

Boon M.R. van der Linden R.A.D.

Arias-Bouda L.P. van Klinken J.B.

Smit F.

Verberne H.J.

Jukema J.W.

Tamsma J.T.

Havekes L.M.

Brown adipose tissue volume in healthy lean south Asian adults compared with white Caucasians: A prospective, case-controlled observational study Lancet Diabetes Endocrinol. 2014 2 210 217 10.1016/S2213-8587(13)70156-6 24622751 50.

Lidell M.E.

Betz M.J.

Enerbäck S.

Brown adipose tissue and its therapeutic potential J. Intern. Med. 2014 276 364 377 10.1111/joim.12255 24717051 51.

Yoneshiro T.

Aita S.

Matsushita M.

Kayahara T.

Kameya T.

Kawai Y.

Iwanaga T.

Saito M.

Recruited brown adipose tissue as an antiobesity agent in humans J. Clin. Investig. 2013 123 3404 3408 10.1172/JCI67803 23867622 PMC3726164 52.

Cypess A.M.

Lehman S.

Williams G.

Tal I.

Rodman D.

Goldfine A.B.

Kuo F.C.

Palmer E.L.

Tseng Y.-H.

Doria A.

Identification and importance of brown adipose tissue in adult humans N. Engl. J. Med. 2009 360 1509 1517 10.1056/NEJMoa0810780 19357406 PMC2859951 53. van Marken Lichtenbelt W.D.

Vanhommerig J.W.

Smulders N.M.

Drossaerts J.M.A.F.L.

Kemerink G.J.

Bouvy N.D.

Schrauwen P.

Teule G.J.J.

Cold-activated brown adipose tissue in healthy men N. Engl. J. Med. 2009 360 1500 1508 10.1056/NEJMoa0808718 19357405 54.

Johnson F.

Mavrogianni A.

Ucci M.

Vidal-Puig A.

Wardle J.

Could increased time spent in a thermal comfort zone contribute to population increases in obesity? Obes. Rev. 2011 12 543 551 10.1111/j.1467-789X.2010.00851.x 21261804 55.

Pontzer H.

Durazo-Arvizu R.

Dugas L.R.

Plange-Rhule J.

Bovet P.

Forrester T.E.

Lambert E.V.

Cooper R.S.

Schoeller D.A.

Luke A.

Constrained Total Energy Expenditure and Metabolic Adaptation to Physical Activity in Adult Humans Curr. Biol. 2016 26 410 417 10.1016/j.cub.2015.12.046 26832439 PMC4803033 56.

Westerterp K.R.

Diet induced thermogenesis Nutr. Metab. 2004 1 5 10.1186/1743-7075-1-5 PMC524030 15507147 57.

Donahoo W.T.

Levine J.A.

Melanson E.L.

Variability in energy expenditure and its components Curr. Opin. Clin. Nutr. Metab. Care 2004 7 599 605 10.1097/00075197-200411000-00003 15534426 58.

Morley N.J.

Lewis J.W.

Temperature stress and parasitism of endothermic hosts under climate change Trends Parasitol. 2014 30 221 227 10.1016/j.pt.2014.01.007 24613288 59.

Vanhaecke T.

Perrier E.T.

Melander O.

A Journey through the Early Evidence Linking Hydration to Metabolic Health Ann. Nutr. Metab. 2020 76 4 9 10.1159/000515021 33774620 60.

Nakamura K.

Velho G.

Bouby N.

Vasopressin and metabolic disorders: Translation from experimental models to clinical use J. Intern. Med. 2017 282 298 309 10.1111/joim.12649 28688111 61.

Blauw L.L.

Aziz N.A.

Tannemaat M.R.

Blauw C.A. de Craen A.J.

Pijl H.

Rensen P.C.N.

Diabetes incidence and glucose intolerance prevalence increase with higher outdoor temperature BMJ Open Diabetes Res. Care 2017 5 e000317 10.1136/bmjdrc-2016-000317 PMC5372132 28405341 62.

Ribble A.

Hellmann J.

Conklin D.J.

Bhatnagar A.

Haberzettl P.

Fine particulate matter (PM 2.5 )-induced pulmonary oxidative stress contributes to increases in glucose intolerance and insulin resistance in a mouse model of circadian dyssynchrony Sci. Total Environ. 2023 877 162934 10.1016/j.scitotenv.2023.162934 36934930 PMC10164116 63.

Zhong J.

Zhao G.

Edwards S.

Tran J.

Rajagopalan S.

Rao X.

Particulate air pollution exaggerates diet-induced insulin resistance through NLRP3 inflammasome in mice Environ. Pollut. 2023 328 121603 10.1016/j.envpol.2023.121603 37062408 PMC10164710 64.

Yang Z.

Dong H.

Gao Y.

Liu S.

Chen L.

Ni G.

Guo X.

Wang M.

Wang C.

Chen Y.

Airborne Nanoplastics Exposure Inducing Irreversible Glucose Increase and Complete Hepatic Insulin Resistance Environ. Sci. Technol. 2024 58 3108 3117 10.1021/acs.est.3c06468 38319870 65.

Gong X.

Wang S.

Wang X.

Zhong S.

Yuan J.

Zhong Y.

Jiang Q.

Long-term exposure to air pollution and risk of insulin resistance: A systematic review and meta-analysis Ecotoxicol. Environ. Saf. 2024 271 115909 10.1016/j.ecoenv.2023.115909 38199220 66.

Zhang K.

Chen G.

He J.

Chen Z.

Pan M.

Tong J.

Liu F.

Xiang H.

DNA methylation mediates the effects of PM 2.5 and O 3 on ceramide metabolism: A novel mechanistic link between air pollution and insulin resistance J. Hazard. Mater. 2024 469 133864 10.1016/j.jhazmat.2024.133864 38457969 67.

Pope C.A.

Coleman N.

Pond Z.A.

Burnett R.T.

Fine particulate air pollution and human mortality: 25+ years of cohort studies Environ. Res. 2020 183 108924 10.1016/j.envres.2019.108924 31831155 68.

Della Guardia L.

Shin A.C.

White and brown adipose tissue functionality is impaired by fine particulate matter (PM 2.5 ) exposure J. Mol. Med. 2022 100 665 676 10.1007/s00109-022-02183-6 35286401 PMC9110515 69.

Burkart K.

Causey K.

Cohen A.J.

Wozniak S.S.

Salvi D.D.

Abbafati C.

Adekanmbi V.

Adsuar J.C.

Ahmadi K.

Alahdab F.

Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: An analysis of data from the Global Burden of Disease Study 2019 Lancet Planet. Health 2022 6 e586 e600 10.1016/S2542-5196(22)00122-X 35809588 PMC9278144 70.

La Merrill M.

Karey E.

Moshier E.

Lindtner C.

La Frano M.R.

Newman J.W.

Buettner C.

Perinatal Exposure of Mice to the Pesticide DDT Impairs Energy Expenditure and Metabolism in Adult Female Offspring PLoS ONE 2014 9 e103337 10.1371/journal.pone.0103337 25076055 PMC4116186 71.

Xu C.-X.

Wang C.

Zhang Z.-M.

Jaeger C.D.

Krager S.L.

Bottum K.M.

Liu J.

Liao D.-F.

Tischkau S.A.

Aryl hydrocarbon receptor deficiency protects mice from diet-induced adiposity and metabolic disorders through increased energy expenditure Int. J. Obes. 2015 39 1300 1309 10.1038/ijo.2015.63 25907315 PMC4526411 72.

Di Gregorio I.

Busiello R.A.

Burgos Aceves M.A.

Lepretti M.

Paolella G.

Lionetti L.

Environmental Pollutants Effect on Brown Adipose Tissue Front. Physiol. 2019 9 1891 10.3389/fphys.2018.01891 30687113 PMC6333681 73.

Feige J.N.

Gerber A.

Casals-Casas C.

Yang Q.

Winkler C.

Bedu E.

Bueno M.

Gelman L.

Auwerx J.

Gonzalez F.J.

The Pollutant Diethylhexyl Phthalate Regulates Hepatic Energy Metabolism via Species-Specific PPARα-Dependent Mechanisms Environ. Health Perspect. 2010 118 234 241 10.1289/ehp.0901217 20123618 PMC2831923 74.

Farrugia F.

Aquilina A.

Vassallo J.

Pace N.P.

Bisphenol A and Type 2 Diabetes Mellitus: A Review of Epidemiologic, Functional, and Early Life Factors Int. J. Environ. Res. Public Health 2021 18 716 10.3390/ijerph18020716 33467592 PMC7830729 75.

Shabalina I.G.

Kalinovich A.V.

Cannon B.

Nedergaard J.

Metabolically inert perfluorinated fatty acids directly activate uncoupling protein 1 in brown-fat mitochondria Arch. Toxicol. 2016 90 1117 1128 10.1007/s00204-015-1535-4 26041126 PMC4830884 76.

John L.M.

Petersen N.

Gerstenberg M.K.

Torz L.

Pedersen K.

Christoffersen B.Ø.

Kuhre R.E.

Housing-temperature reveals energy intake counter-balances energy expenditure in normal-weight, but not diet-induced obese, male mice Commun. Biol. 2022 5 946 10.1038/s42003-022-03895-8 36088386 PMC9464191 77.

Ganeshan K.

Chawla A.

Warming the mouse to model human diseases Nat. Rev. Endocrinol. 2017 13 458 465 10.1038/nrendo.2017.48 28497813 PMC5777302 78.

Kaiyala K.J.

Ogimoto K.

Nelson J.T.

Muta K.

Morton G.J.

Physiological role for leptin in the control of thermal conductance Mol. Metab. 2016 5 892 902 10.1016/j.molmet.2016.07.005 27689002 PMC5034509 79.

Stemmer K.

Kotzbeck P.

Zani F.

Bauer M.

Neff C.

Müller T.D.

Pfluger P.T.

Seeley R.J.

Divanovic S.

Thermoneutral housing is a critical factor for immune function and diet-induced obesity in C57BL/6 nude mice Int. J. Obes. 2015 39 791 797 10.1038/ijo.2014.187 25349057 PMC4412759 80.

Shankar K.

Kumar D.

Gupta S.

Varshney S.

Rajan S.

Srivastava A.

Gupta A.

Gupta A.P.

Vishwakarma A.L.

Gayen J.R.

Role of brown adipose tissue in modulating adipose tissue inflammation and insulin resistance in high-fat diet fed mice Eur. J. Pharmacol. 2019 854 354 364 10.1016/j.ejphar.2019.02.044 30822393 81.

Sass F.

Schlein C.

Jaeckstein M.Y.

Pertzborn P.

Schweizer M.

Schinke T.

Ballabio A.

Scheja L.

Heeren J.

Fischer A.W.

TFEB deficiency attenuates mitochondrial degradation upon brown adipose tissue whitening at thermoneutrality Mol. Metab. 2021 47 101173 10.1016/j.molmet.2021.101173 33516944 PMC7903014 82.

Spiljar M.

Steinbach K.

Rigo D.

Suárez-Zamorano N.

Wagner I.

Hadadi N.

Vincenti I.

Page N.

Klimek B.

Rochat M.-A.

Cold exposure protects from neuroinflammation through immunologic reprogramming Cell Metab. 2021 33 2231 2246.e8 10.1016/j.cmet.2021.10.002 34687652 PMC8570411 83.

Williams J.W.

Elvington A.

Ivanov S.

Kessler S.

Luehmann H.

Baba O.

Saunders B.T.

Kim K.-W.

Johnson M.W.

Craft C.S.

Thermoneutrality but Not UCP1 Deficiency Suppresses Monocyte Mobilization Into Blood Circ. Res. 2017 121 662 676 10.1161/CIRCRESAHA.117.311519 28696252 PMC5718914 84.

Presby D.M.

Jackman M.R.

Rudolph M.C.

Sherk V.D.

Foright R.M.

Houck J.A.

Johnson G.C.

Orlicky D.J.

Melanson E.L.

Higgins J.A.

Compensation for cold-induced thermogenesis during weight loss maintenance and regain Am. J. Physiol. Metab. 2019 316 E977 E986 10.1152/ajpendo.00543.2018 30912962 PMC6580173 85.

Søberg S.

Löfgren J.

Philipsen F.E.

Jensen M.

Hansen A.E.

Ahrens E.

Nystrup K.B.

Nielsen R.D.

Sølling C.

Wedell-Neergaard A.-S.

Altered brown fat thermoregulation and enhanced cold-induced thermogenesis in young, healthy, winter-swimming men Cell Rep. Med. 2021 2 100408 10.1016/j.xcrm.2021.100408 34755128 PMC8561167 86.

González-García I.

Milbank E.

Diéguez C.

López M.

Contreras C.

Glucagon, GLP-1 and Thermogenesis Int. J. Mol. Sci. 2019 20 3445 10.3390/ijms20143445 31337027 PMC6678955 87.

Ravussin Y.

Xiao C.

Gavrilova O.

Reitman M.L.

Effect of Intermittent Cold Exposure on Brown Fat Activation, Obesity, and Energy Homeostasis in Mice PLoS ONE 2014 9 e85876 10.1371/journal.pone.0085876 24465761 PMC3895006 88.

Boström P.

Wu J.

Jedrychowski M.P.

Korde A.

Ye L.

Lo J.C.

Rasbach K.A.

Boström E.A.

Choi J.H.

Long J.Z.

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis Nature 2012 481 463 468 10.1038/nature10777 22237023 PMC3522098 89.

Weng X.

Wang C.

Yuan Y.

Wang Z.

Kuang J.

Yan X.

Chen H.

Effect of Cold Exposure and Exercise on Insulin Sensitivity and Serum Free Fatty Acids in Obese Rats Med. Sci. Sport. Exerc. 2023 55 1409 1415 10.1249/MSS.0000000000003173 36924336 90.

Mancini S.J.

White A.D.

Bijland S.

Rutherford C.

Graham D.

Richter E.A.

Viollet B.

Touyz R.M.

Palmer T.M.

Salt I.P.

Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptor-associated kinase-4 phosphorylation Mol. Cell. Endocrinol. 2017 440 44 56 10.1016/j.mce.2016.11.010 27840174 PMC5228585 91.

Xu R.

Zhong Y.

Li R.

Li Y.

Zhong Z.

Liu T.

Wang Q.

Lv Z.

Huang S.

Duan Y.-G.

Association between exposure to ambient air pollution and semen quality: A systematic review and meta-analysis Sci. Total Environ. 2023 870 161892 10.1016/j.scitotenv.2023.161892 36731563 92.

Mendez R.

Zheng Z.

Fan Z.

Rajagopalan S.

Sun Q.

Zhang K.

Exposure to fine airborne particulate matter induces macrophage infiltration, unfolded protein response, and lipid deposition in white adipose tissue Am. J. Transl. Res. 2013 5 224 234 23573366 PMC3612517 93.

Wang N.

Ma Y.

Liu Z.

Liu L.

Yang K.

Wei Y.

Liu Y.

Chen X.

Sun X.

Wen D.

Hydroxytyrosol prevents PM 2.5 -induced adiposity and insulin resistance by restraining oxidative stress related NF-κB pathway and modulation of gut microbiota in a murine model Free Radic. Biol. Med. 2019 141 393 407 10.1016/j.freeradbiomed.2019.07.002 31279968 94.

Campolim C.M.

Weissmann L.

Ferreira C.K.D.O.

Zordão O.P.

Dornellas A.P.S. de Castro G.

Zanotto T.M.

Boico V.F.

Quaresma P.G.F.

Lima R.P.A.

Short-term exposure to air pollution (PM 2.5 ) induces hypothalamic inflammation, and long-term leads to leptin resistance and obesity via Tlr4/Ikbke in mice Sci. Rep. 2020 10 10160 10.1038/s41598-020-67040-3 32576879 PMC7311527 95.

Hersoug L.-G.

Møller P.

Loft S.

Role of microbiota-derived lipopolysaccharide in adipose tissue inflammation, adipocyte size and pyroptosis during obesity Nutr. Res. Rev. 2018 31 153 163 10.1017/S0954422417000269 29362018 96.

Daiber A.

Kuntic M.

Hahad O.

Delogu L.G.

Rohrbach S.

Di Lisa F.

Schulz R.

Münzel T.

Effects of air pollution particles (ultrafine and fine particulate matter) on mitochondrial function and oxidative stress—Implications for cardiovascular and neurodegenerative diseases Arch. Biochem. Biophys. 2020 696 108662 10.1016/j.abb.2020.108662 33159890 97.

Burgoine T.

Monsivais P.

Sharp S.J.

Forouhi N.G.

Wareham N.J.

Independent and combined associations between fast-food outlet exposure and genetic risk for obesity: A population-based, cross-sectional study in the UK BMC Med. 2021 19 49 10.1186/s12916-021-01902-z 33588846 PMC7885578 98.

Zhao Z.

Zhen S.

Yan Y.

Liu N.

Ding D.

Kong J.

Association of dietary patterns with general and central obesity among Chinese adults: A longitudinal population-based study BMC Public Health 2023 23 1588 10.1186/s12889-023-16556-0 37605199 PMC10440870 99.

Miguel E.D.S.

Lopes S.O.

Araújo S.P.

Priore S.E.

Alfenas R.d.C.G.

Hermsdorff H.H.M.

Association between food insecurity and cardiometabolic risk in adults and the elderly: A systematic review J. Glob. Health 2020 10 020402 10.7189/jogh.10.020402 33110569 PMC7568919 100.

Nkambule S.J.

Moodley I.

Kuupiel D.

Mashamba-Thompson T.P.

Association between food insecurity and key metabolic risk factors for diet-sensitive non-communicable diseases in sub-Saharan Africa: A systematic review and meta-analysis Sci. Rep. 2021 11 5178 10.1038/s41598-021-84344-0 33664339 PMC7933340 101.

Turner C.

Kalamatianou S.

Drewnowski A.

Kulkarni B.

Kinra S.

Kadiyala S.

Food Environment Research in Low- and Middle-Income Countries: A Systematic Scoping Review Adv. Nutr. 2020 11 387 397 10.1093/advances/nmz031 31079142 PMC7442349 102. von Braun J.

Economic and Political Innovation for Nutritional Improvement World Rev. Nutr. Diet. 2018 118 1 9 10.1159/000484513 29656283 103.

Owino V.

Kumwenda C.

Ekesa B.

Parker M.E.

Ewoldt L.

Roos N.

Lee W.T.

Tome D.

The impact of climate change on food systems, diet quality, nutrition, and health outcomes: A narrative review Front. Clim. 2022 4 941842 10.3389/fclim.2022.941842 104.

Hallström E.

Bajzelj B.

Håkansson N.

Sjons J.

Åkesson A.

Wolk A.

Sonesson U.

Dietary climate impact: Contribution of foods and dietary patterns by gender and age in a Swedish population J. Clean. Prod. 2021 306 127189 10.1016/j.jclepro.2021.127189 105.

Domingo N.G.G.

Balasubramanian S.

Thakrar S.K.

Clark M.A.

Adams P.J.

Marshall J.D.

Muller N.Z.

Pandis S.N.

Polasky S.

Robinson A.L.

Air quality–related health damages of food Proc. Natl. Acad. Sci. USA 2021 118 e2013637118 10.1073/pnas.2013637118 33972419 PMC8158015 106.

Sundram T.K.M.

Tan E.S.S.

Lim H.S.

Amini F.

Bustami N.A.

Tan P.Y.

Rehman N.

Ho Y.B.

Tan C.K.

Effects of Ambient Particulate Matter (PM 2.5 ) Exposure on Calorie Intake and Appetite of Outdoor Workers Nutrients 2022 14 4858 10.3390/nu14224858 36432544 PMC9699249 107.

Myers S.S.

Zanobetti A.

Kloog I.

Huybers P.

Leakey A.D.B.

Bloom A.J.

Carlisle E.

Dietterich L.H.

Fitzgerald G.

Hasegawa T.

Increasing CO2 threatens human nutrition Nature 2014 510 139 142 10.1038/nature13179 24805231 PMC4810679 108.

Rezaei E.E.

Webber H.

Asseng S.

Boote K.

Durand J.L.

Ewert F.

Martre P.

MacCarthy D.S.

Climate change impacts on crop yields Nat. Rev. Earth Environ. 2023 4 831 846 10.1038/s43017-023-00491-0 109.

Young B.

Birney C.

Ingwersen W.W.

Dataset of 2012-2020 U.S. National- and State-Level Greenhouse Gas Emissions by Sector Data Br. 2024 53 110173 10.1016/j.dib.2024.110173 38406244 PMC10885542 110.

Flint E.

Webb E.

Cummins S.

Change in commute mode and body-mass index: Prospective, longitudinal evidence from UK Biobank Lancet Public Health 2016 1 e46 e55 10.1016/S2468-2667(16)30006-8 28299370 PMC5341146 111.

Haines A.

Ebi K.

The Imperative for Climate Action to Protect Health N. Engl. J. Med. 2019 380 263 273 10.1056/NEJMra1807873 30650330 112.

Hirvonen K.

Bai Y.

Headey D.

Masters W.A.

Affordability of the EAT–Lancet reference diet: A global analysis Lancet Glob. Health 2020 8 e59 e66 10.1016/S2214-109X(19)30447-4 31708415 PMC7024996 113.

Landrigan P.J.

Fuller R.

Acosta N.J.R.

Adeyi O.

Arnold R.

Basu N.

Baldé A.B.

Bertollini R.

Bose-O’Reilly S.

Boufford J.I.

The Lancet Commission on pollution and health Lancet 2018 391 462 512 10.1016/S0140-6736(17)32345-0 29056410 114.

Jay O.

Capon A.

Berry P.

Broderick C. de Dear R.

Havenith G.

Honda Y.

Kovats R.S.

Ma W.

Malik A.

Reducing the health effects of hot weather and heat extremes: From personal cooling strategies to green cities Lancet 2021 398 709 724 10.1016/S0140-6736(21)01209-5 34419206 115.

Carlsten C.

Salvi S.

Wong G.W.K.

Chung K.F.

Personal strategies to minimise effects of air pollution on respiratory health: Advice for providers, patients and the public Eur. Respir. J. 2020 55 1902056 10.1183/13993003.02056-2019 32241830 PMC7270362 116.

Dain K.

Hadley L.

Diabetes and climate change—Two interconnected global challenges Diabetes Res. Clin. Pract. 2012 97 337 339 10.1016/j.diabres.2012.07.002 22890699 Figure 1 Adipose tissue responses to thermal challenges. ( a ) In BAT, polarized macrophages, due to cold exposure, directly activate beta-adrenergic signaling, thereby increasing heat production. ( b ) Energy expenditure is triggered by the body’s cooling mechanisms when the temperature exceeds the thermoneutral zone. ( c ) The elevated thermogenic activity of brown and beige adipocytes due to cold exposure is a result of increased glucose and free fatty acid uptake. ( d ) The browning of WAT is an important mechanism in which cold exposure triggers an increase in the oxidative metabolic rates of brown and beige adipocytes. This is essential for maintaining core body temperature during prolonged cold exposure. Created with BioRender.com . Figure 2 Addressing global challenges related to obesity and climate. ( a ) Obesity is triggered by high levels of greenhouse gas emissions due to increased food intake. ( b ) An important factor contributing to obesity is the increased time spent in the thermoneutral zone and decreased thermogenesis as a consequence. ( c ) A protein-rich diet is recommended due to it having the highest effect on diet-induced thermogenesis. ( d ) The increase in the consumption of processed foods is attributed to increased temperatures negatively impacting crop yields and agriculture. ( e ) Physical inactivity, as a result of extreme temperatures, contributes to weight gain. Created with BioRender.com . Figure 3 Effects of heat exposure and air pollution on insulin resistance and diabetes complications. ( a ) Exposure to high temperatures increases sweat secretion and peripheral vasodilation. This, in turn, dissipates heat and maintains optimal body temperature. ( b ) Impairment of insulin signaling stimulates insulin resistance in various tissues due to dehydration caused by heat exposure. ( c ) Glucose intolerance is a consequence of disruption of thermoregulation by impairment of orthostatic response. ( d ) Air pollutants, specifically PM2.5, increase risk of glucose intolerance and type 2 DM-associated cardiovascular diseases. Created with BioRender.com .

📖 中文全文 Chinese Full Text

中文

# 与气候变化和空气污染相关的脂肪组织功能障碍:理解代谢后果

## 摘要

肥胖症作为一种全球性大流行,对全球医疗系统构成重大威胁。脂肪组织是在能量摄入过剩时储存能量的器官,同时作为体温调节器,与其他组织相互作用以调节全身代谢。具体而言,棕色脂肪组织(BAT)与肥胖抵抗力的增强呈正相关,这归因于其在解偶联蛋白1(UCP1)存在下的产热功能。近年来,关于气候变化和环境污染因素对能量稳态及肥胖影响的研究日益受到关注。肥胖程度加剧与气温升高之间的相互关系导致适应性产热减少、体力活动下降以及碳足迹增加。此外,气候变化的影响使肥胖个体更易罹患2型糖尿病(T2DM)。热应激反应受损、血管舒张功能减弱及出汗功能障碍增加了糖尿病相关合并症的风险。本综述全面介绍了气候变化对肥胖和脂肪组织的影响、T2DM发病风险,以及导致脂肪组织功能障碍和空气污染的环境污染物相关研究进展。同时讨论了饮食模式改变对肥胖的影响,以及减轻气候变化不利影响的适应策略。

**关键词:** 气候变化;肥胖;白色脂肪组织;棕色脂肪组织;空气污染;肥胖症;脂肪组织功能障碍

---

## 1. 引言

肥胖是指脂肪过度蓄积的状态,当能量摄入超过能量过剩时发生,导致多余能量以白色脂肪组织(WAT)的形式储存。这种能量稳态失衡会导致多种代谢紊乱,包括2型糖尿病(T2DM)。另一方面,棕色脂肪组织(BAT)以棕色多房脂肪细胞为特征,通过刺激产热来增加能量消耗,从而对抗WAT中的过度脂肪蓄积,因此成为治疗肥胖和代谢紊乱的有前景的靶点[1,2]。

肥胖是T2DM发生和发展的重要危险因素[3]。不健康的饮食模式、肥胖和缺乏体力活动进一步加剧了T2DM的患病率[4]。作为全球性健康挑战,肥胖和T2DM均受到多种环境因素的影响,包括气候变化和日益严重的空气污染。现有文献支持以下假设:某些环境污染物,如二氯二苯基三氯乙烷(DDT)及其代谢产物二氯二苯基乙烯(DDE),通过损害BAT的质量和功能与肥胖发生率增加相关。DDE和DDT是持久性有机污染物,过去曾被广泛用作农药,由于其降解缓慢,至今仍存在于环境中[5]。

空气污染物,尤其是细颗粒物(PM2.5),通过诱导BAT线粒体功能障碍导致胰岛素抵抗(IR)[6]。BAT受寒冷暴露和胰岛素刺激,与体重指数(BMI)呈负相关。此外,产热基因表达的改变是肥胖和IR的关键特征[2]。肥胖程度加剧与气温升高之间的联系导致适应性产热减少、体力活动下降以及碳足迹增加。此外,气候变化的影响使肥胖个体更易罹患T2DM。气候变化引起的热应激反应受损、血管舒张功能减弱及出汗功能障碍增加了糖尿病相关合并症的风险。

本综述旨在全面分析气候变化、空气污染和环境因素对脂肪组织功能和代谢健康的影响。我们还探讨了气温升高和环境污染物如何影响WAT和BAT,从而促进肥胖和T2DM的发生。此外,我们还讨论了应对这些全球挑战不利影响的潜在适应和缓解策略。

---

## 2. 脂肪组织与代谢健康

脂肪组织作为代谢库,在调节脂质代谢和葡萄糖稳态方面发挥着多种功能。代谢性疾病,如IR、炎症、脂质过载和内质网(ER)应激,与脂肪组织功能障碍密切相关。功能失调的脂肪组织导致肥胖个体中脂肪细胞特征和脂肪沉积分布的差异[7]。

在能量过剩条件下,脂肪细胞除了利用细胞内通过从头脂肪生成从乙酰辅酶A转化的脂肪酸外,还从循环中释放的游离脂肪酸(FFAs)合成甘油三酯(TGs)[8]。此外,脂肪细胞体积增大(肥大),并从前脂肪细胞募集额外的脂肪细胞(增生)。在这些过程中,随后发生的广泛组织重塑和炎症激活导致肥胖、IR和代谢功能障碍[8]。与此一致,不良代谢后果显而易见,包括异位部位内脏脂肪堆积、血脂异常和脂肪营养不良[9,10]。

了解脂肪组织在葡萄糖稳态中的作用至关重要。产热脂肪组织在肾上腺素能刺激下充当葡萄糖库,葡萄糖转运蛋白4型(GLUT4)的表达参与外周葡萄糖处置[11]。脂肪组织释放的关键激素包括瘦素、脂联素和抵抗素。瘦素增加能量消耗,其水平与脂肪组织质量相关。肥胖状态以瘦素抵抗为特征,因此瘦素水平升高作为一种代偿机制[12]。另一方面,脂联素抑制肝脏葡萄糖生成并增强肌肉葡萄糖摄取[13]。

最新研究进一步阐明了脂肪组织功能障碍与代谢紊乱和肥胖之间的机制联系,强调了脂肪生成受损、脂肪因子分泌改变、慢性低度炎症、FFA水平升高和异位脂质蓄积的作用[14,15]。在肥胖中,由于脂肪组织炎症和肿瘤坏死因子α(TNFα)水平升高干扰了胰岛素信号传导,脂肪生成与脂肪分解之间的平衡被破坏[10,16]。胰岛素响应代谢组织中的异位脂质蓄积(也称为脂毒性)损害胰岛素信号传导[4]。

### 2.1. WAT与代谢健康

WAT是体内脂肪的主要类型,分为两个关键亚组:皮下WAT(sWAT,位于皮肤下方)和内脏WAT(vWAT,围绕腹部器官分布)[7]。sWAT是脂质储存的主要库[17],提供隔热保护、抗感染保护和缓解机械应力[8]。vWAT在健康个体中通常少量存在,但代谢活性极高,向血液中释放FFAs。在肥胖中,多余脂肪在vWAT和其他异位部位(如心脏、血管、消化器官、肝脏和肾脏周围)蓄积,导致胰岛素过度产生和抵抗、炎症及动脉脂肪沉积[8,9]。

WAT是能量储存的主要部位,以三酰甘油形式储存,具有高度可塑性。因此,WAT能够对各种代谢刺激(如饮食、运动和肥胖)作出反应而扩张、缩小和重塑[18]。sWAT扩张的能力是肥胖中代谢失调的关键决定因素[19]。当能量失衡时,WAT容纳多余脂肪的生理能力被超越,触发细胞器应激、组织缺氧、细胞外基质成分积累、免疫细胞浸润组织、线粒体功能障碍和脂滴异常[20,21,22]。

此外,WAT作为重要的内分泌器官,通过分泌多种内分泌因子(如脂肪因子、激素、生长因子和炎症因子)来调节代谢过程、炎症和胰岛素敏感性。这些分泌物在维持能量平衡和整体代谢健康方面发挥着关键作用。

### 2.2. BAT与代谢健康

BAT的独特性在于其表达解偶联蛋白1(UCP1),这是一种线粒体内膜蛋白,通过将线粒体质子梯度与ATP生成解偶联以产生热量来负责产热[17]。另一类脂肪细胞,即米色脂肪细胞,也表达UCP1,但利用不依赖UCP1的产热机制,如Ca²⁺循环[17]。除了调节产热外,BAT还参与与多种外周组织(如肝脏、骨骼肌和免疫细胞)的串扰,以调节全身能量平衡和葡萄糖稳态[23]。

值得注意的是,BAT分泌棕色脂肪因子(BATokines),如成纤维细胞生长因子21(FGF21)、白细胞介素-6(IL-6)、生长分化因子15(GDF-15)等[24]。研究表明,源自棕色脂肪细胞的人多能细胞显著改善葡萄糖和脂质代谢并预防肥胖[25]。近期研究报告了人BAT与较低TG水平、血糖水平和较高高密度脂蛋白(HDL)水平之间的关联[26]。

在急性或轻度寒冷暴露反应中,BAT激活通过非颤抖性产热维持热需求[27]。冷适应增加BAT的氧化能力,这与颤抖性产热减少相关。此外,BAT中的冷适应还与线粒体重塑和血管化相关,以通过UCP1在高代谢需求期间实现适应性产热和脂肪酸氧化[28,29]。

BAT的生理调节主要通过棕色脂肪细胞中存在的β-3-肾上腺素能受体介导[30]。此外,BAT在葡萄糖代谢中发挥关键作用。寒冷暴露对肾上腺素能信号的刺激诱导GLUT1和GLUT4向棕色脂肪细胞质膜的转位[11]。BAT对葡萄糖的摄取还受胰岛素信号通过磷脂酰肌醇3-激酶(PI3K)-磷酸肌醇依赖性激酶-1(PDK1)-蛋白激酶B(PKB/Akt)信号通路调节,促进GLUT4向质膜的转位[11]。

治疗肥胖和代谢紊乱的主要策略是通过称为"脂肪细胞褐变"的过程操纵WAT向具有增强产热能力的人源样表型转化[31]。

---

## 3. 气候变化对脂肪组织的影响

气候变化显著影响脂肪组织功能和代谢,加剧肥胖和代谢紊乱的患病率。全球变暖相关的气温升高损害BAT产热,减少能量消耗并增加肥胖程度[32]。此外,气候变化相关因素(如空气污染和饮食模式改变)破坏脂肪组织稳态,增加代谢功能障碍的风险[33]。气温升高还对内温物种的体温调节构成挑战,给补偿机制带来负担并增加热应激风险[34]。这些环境压力因素,加上极端天气事件和森林砍伐,通过影响营养、体力活动水平和整体代谢健康进一步加剧了这一问题[35]。

脂肪组织在维持能量稳态中的作用对代谢紊乱的病理生理学至关重要。已知多种反应(如血管收缩和立毛)可在哺乳动物中应对热挑战时维持核心体温[36]。颤抖性产热是对应激热的急性反应,表现为肌肉持续收缩和放松。相比之下,非颤抖性产热发生在BAT中,在慢性寒冷暴露期间产生热量,这是应对冷挑战的长期策略[37,38]。

值得注意的是,当温度低于热中性区时,由于维持体温所需的能量增加,代谢率会升高(图1a)。然而,当温度超过热中性区时,身体的冷却机制会激活能量消耗[39](图1b)。除BAT外,sWAT和腹股沟WAT(iWAT)在不同温度下也会发生形态学变化。例如,在寒冷环境中,sWAT和iWAT经历褐变过程[40,41]。

寒冷暴露诱导BAT中巨噬细胞的极化改变。这些极化巨噬细胞通过产生儿茶酚胺直接激活脂肪细胞中的β-肾上腺素能信号来促进产热[42](图1c)。简言之,寒冷暴露刺激棕色和米色脂肪细胞氧化代谢速率的增加,导致葡萄糖和游离脂肪酸摄取增加(图1d)。

### 3.1. 气候变化与肥胖

令人担忧的是,全球有超过8.9亿成年人(即八分之一的人)受到肥胖的影响[43]。值得注意的是,61%的糖尿病患者为肥胖患者。自1975年以来,全球肥胖率几乎增加了两倍[44]。

全球变暖由温室气体(GHG)排放增加引起,如CO₂、甲烷、一氧化二氮、臭氧和氟化气体(如氯氟烃[CFCs]和氢氟烃[HFCs])[45]。青少年至成人健康纵向研究(Add Health)表明,大气温度与体重轻微增加相关[46]。由于更大的代谢需求和食物摄入增加导致的氧化代谢增加可能是高GHG排放的结果[47](图2a)。

肥胖源于多种因素,如高热量摄入、缺乏体力活动和能量耗散减少。由于干扰激素代谢的化学物质导致编码解偶联蛋白、甲状腺激素受体和β-肾上腺素能受体的产热基因表达降低,从而促进受损的产热,进而增加体重[48]。

多项研究发现,产热(即棕色或米色脂肪细胞促进能量消耗增加的过程)在不同人群中存在差异[49,50,51],其中一些差异可能归因于环境因素[52,53]。在热中性区停留时间延长可导致BAT减少和产热活性降低[54](图2b)。

研究表明,产热在中度体力活动水平以上趋于平稳。关于饮食诱导的产热,以热量形式释放的能量因食物消耗的宏量营养素组成而异。脂肪的热效应最低(0-3%),其次是碳水化合物(5-10%),蛋白质最高(20-30%)[55,56](图2c)。饮食诱导的产热的变异性可归因于性别、年龄、身体成分和激素状态等因素[57]。

环境温度暴露对BAT活性起重要作用。在热舒适区停留时间增加会减少能量消耗,并可能产生致肥胖后果。在高温下,神经内分泌机制减少食物摄入和代谢,导致甲状腺活性及睾酮和皮质醇水平降低[58]。相反,低温会增加肾上腺固醇激素水平以及垂体和甲状腺的活性。

气温升高对农业产生负面影响,导致新鲜农产品稀缺。GHG排放增加间接促进了加工食品的高产量,原因包括新鲜食品的供应减少和价格上涨。加工食品的消费增加(其特征为高盐、高糖和高脂肪含量)导致多种健康问题,包括肥胖和代谢紊乱[33](图2d)。此外,极端温度对体力活动水平产生负面影响,导致久坐不动的生活方式[33](图2e)。

### 3.2. 气候变化与T2DM

暴露于高温时,人体通过外周血管舒张、增加汗液分泌以散热以及将血流重新分布至皮肤来作出反应。这些反应导致热量散失,旨在维持最佳体温[59](图3a)。

皮肤血流量增加可能导致脱水和胰岛素信号传导及葡萄糖处置受损,其机制为抑制细胞胰岛素作用和减少流向胰岛素敏感组织的血流。此外,脱水通过破坏下游信号通路(如PI3K)和高渗抑制PKB激活来促进IR。值得注意的是,脱水引起的血管加压素水平升高刺激肝脏葡萄糖生成,并促进肝脏、脂肪组织和胰腺中的IR[60](图3b)。

在T2DM中,高温还可能通过损害直立反应来破坏体温调节[32]。Blauw等人[61]估计,室外温度每升高1摄氏度,美国每年可能新增10万例糖尿病病例(图3c)。

多项研究报告空气污染增加IR及其相关并发症[62,63,64,65]。空气污染物(如臭氧和细颗粒物[PM])可导致糖尿病并发症[66]。粒径达2.5μm的细颗粒物(PM2.5)是由人类和自然来源产生的有机和无机化学品的混合物,由碳质核组成,从大气中吸收多环芳烃和内毒素金属[67,68]。已知PM2.5会增加T2DM及其相关心血管疾病(CVD)的风险[69](图3d)。

---

## 4. 影响脂肪组织代谢的环境因素

脂肪组织在应对能量过载和温度变化时经历增生和肥大。围产期暴露于内分泌干扰物(如DDT)可能损害BAT产热并增加代谢综合征的风险[70]。此外,空气污染通过BAT线粒体功能障碍增加IR风险。将产热与IR风险联系起来的机制涉及过氧化物酶体增殖物激活受体-γ共激活因子-1-α(PGC-1α)的激活,PGC-1α是能量代谢的主调节因子[70]。

此外,DDT和DDE对BAT的影响可能通过芳烃受体(AHR)介导,AHR是能量代谢的生理性碳调节因子。促炎性细胞因子增加AHR激活[71]。简言之,DDT及其代谢产物DDE诱导核因子-κB(NF-κB)激活和促炎性细胞因子产生,从而介导AHR的上调[71]。

### 4.1. 空气污染物与BAT

研究表明,长期暴露于PM2.5可诱导炎症并减少BAT重量、BAT中的线粒体大小和WAT中的线粒体数量,这些变化与BAT"白化"过程相关[68]。有趣的是,WAT特征性基因——同源框蛋白C9(HOXC9)和胰岛素样生长因子结合蛋白3(IGFBP3)——在BAT中上调,支持棕色脂肪细胞向WAT表型的转化[72]。

Zhang等人[6]提出PM2.5可能通过TNFα介导的凋亡和炎症影响BAT发育。BAT炎症与胰岛素信号传导受损相关,证据是BAT中AKT的Ser437磷酸化减少[68]。此外,长期暴露于PM2.5诱导下丘脑低度炎症,间接导致BAT功能障碍。其他污染物,如单-2-乙基己基邻苯二甲酸酯(MEHP),促进脂肪细胞分化并诱导小鼠肥胖[73]。

Farrugia等人[74]的研究表明双酚A(BPA)与肥胖、糖尿病和代谢紊乱之间存在相关性。相反,多氟烷基物质(PFAS),如全氟辛酸(PFOA)和全氟辛烷磺酸盐(PFOS),通过UCP1上调增加棕色脂肪线粒体的氧化能力,具有抗肥胖作用[75]。

DDT和DDE通过多种机制损害BAT活性,包括减少底物转运和利用、下调参与产热基因的表达、抑制甲状腺素(T4)向三碘甲状腺原氨酸(T3)的脱碘,以及诱导BAT中的IR和炎症通路[70]。相反,PFOA和PFOS通过BAT中UCP1上调增加线粒体氧化,从而减少食物摄入和体重。

### 4.2. BAT功能和代谢的温度相关适应

温度变化改变脂肪组织的生理和分子方面,以调整到新的组织稳态。对小鼠的研究揭示了由于热挑战导致的代谢率差异。温度从30°C逐渐降低至轻度寒冷温度(16-20°C)再至严重寒冷温度(5°C)会导致耗氧量逐渐增加[76]。因此,当温度降低时,由于维持体温需要更多能量,代谢率会增加。另一方面,当环境温度超过热中性区并激活身体冷却机制时,能量消耗受到刺激[77]。

一项研究展示了在14°C、22°C和30°C饲养ob/ob小鼠对其核心温度和能量消耗的影响。在该情况下,ob/ob小鼠的低体温表型通过瘦素给药得到部分挽救,同时热导率降低,证明了在亚热中性条件下瘦素在维持核心体温方面的生理作用[78]。

环境温度在确定小鼠代谢表型中起关键作用。例如,裸鼠表现出热绝缘降低,可能激活代偿性产热程序,如BAT和米色脂肪细胞介导的非颤抖性产热(NST),导致能量消耗增加[79]。众所周知,BAT活性改善肥胖诱导的代谢功能障碍。然而,棕色脂肪细胞缺乏会增加体重、IR和脂肪组织炎症[80]。

BAT在室温下具有多房棕色脂肪细胞,而在热中性(TN)区具有单房棕色脂肪细胞。此外,在寒冷温度下,iWAT由多房脂肪细胞组成,表明发生褐变事件,这在TN区完全消失[40]。此外,在TN区,白化的BAT表现出线粒体密度和基因及蛋白表达降低[81]。

寒冷暴露诱导BAT和米色脂肪组织(BeAT)中巨噬细胞的替代极化,通过产生儿茶酚胺诱导产热并直接激活脂肪细胞中的β-肾上腺素能信号[82]。另一个重要特征是免疫细胞组成的改变;在TN区系统性导致骨髓中淋巴细胞抗原6复合物、基因座G(LYG6)+单核细胞积累。此外,小鼠血清中TNFα和IL-6水平升高[83]。相反,寒冷暴露导致活化的单核细胞减少和自身免疫中T细胞表达降低[82]。

间歇性寒冷暴露(ICE)(将身体短时间暴露于低温)已知可增加皮下WAT,并对内脏WAT产生可变影响。ICE通过增加小鼠能量消耗来促进体重维持并减轻复发性正能量平衡[84]。大量研究表明ICE增加BAT激活并减少体重[85]。

ICE诱导全身性反应以保护核心体温。例如,ICE引起的胰高血糖素增加通过激活FGF21分泌充当褐变刺激。UCP1高表达、高底物转换率和丰富的线粒体是ICE生理反应中串扰网络的其他改变[86]。在BAT中,UCP1和过氧化物酶体增殖物激活受体-γ(PPARγ)表达的诱导通过增加脂蛋白脂肪酶(LPL)表达来增加脂肪利用能力[87]。此外,对冷高度敏感的米色脂肪细胞对肌肉分泌的鸢尾素敏感性增加[88]。

了解寒冷暴露对脂肪组织分泌功能的影响至关重要,特别是脂肪因子在血糖和胰岛素敏感性中的调节作用;然而,将ICE与脂肪因子调节联系起来的直接证据有限。Wang等人[89]报道,在大鼠中ICE与运动联合使用可降低IR和血糖水平。此外,腹股沟脂肪组织中脂肪甘油三酯脂肪酶(ATGL)和LPL活性被证明在ICE反应中增加。此外,ICE通过PGC1α和p38 MAPK上调增强骨骼肌氧化FFAs的能力[89]。由于大量研究以啮齿动物模型为中心,需要进一步研究ICE对人类的影响。

### 4.3. 空气污染物与WAT功能障碍

长期暴露于PM2.5与WAT扩张和肥胖程度增加相关[90]。除了刺激脂肪生成外,PM2.5还减少儿茶酚胺诱导的脂肪分解。此外,PM2.5暴露与甲状腺功能改变及T3和T4血浆水平降低相关[67,91]。在骨骼肌中,PM2.5暴露抑制NO依赖性微血管舒张并降低线粒体氧化能力[67]。

多项啮齿动物研究结果表明,暴露于PM2.5诱导脂肪细胞肥大和WAT扩张。值得注意的是,PM2.5直接氧化有机分子并刺激活性氧(ROS)产生,干扰细胞中的线粒体呼吸链[68]。证据表明,长期暴露于PM2.5会增加啮齿动物中脂肪生成基因的表达,如编码乙酰辅酶A羧化酶(ACC)和二酰甘油O-酰基转移酶2(DGAT2)的基因,同时PPARα和cAMP反应元件结合蛋白α(CREB-α)增加[92,93]。

重要的是,暴露于PM2.5导致与瘦素抵抗相关的下丘脑炎症,能量消耗减少和WAT积累[94]。此外,它与肠道通透性增加相关,导致细菌LPS迁移和促炎分子释放,刺激WAT炎症和脂肪生成。此外,长期暴露于PM2.5导致WAT和BAT中线粒体数量和大小显著减少,抑制PCG-1α和UCP1,并导致脂质代谢受损、氧化应激增加、线粒体功能障碍和白色脂肪细胞中TG储存增加[95,96]。

### 4.4. 气候变化、空气污染与饮食模式改变之间的关联

不健康的饮食习惯,如高摄入油炸食品和富含糖的食物以及减少红肉、水果和水果的摄入,导致中枢性和全身性肥胖。此外,这些饮食习惯与成年人久坐行为相关[97]。高白面包摄入也与成年人中枢性和全身性肥胖相关[98]。

研究表明,食物供应、获取和利用可在很大程度上影响饮食模式,导致高热量或加工食品的消费。这还导致必需营养素(如蛋白质、维生素和矿物质)的摄入不足,促进血脂异常和中枢性肥胖增加[99,100]。

气候变化还影响土壤肥力、降雨模式、作物产量、食物生产和营养素生物利用度[101]。重要的是要注意,食物生产与气候变化之间存在相互和循环关联。化肥使用增加和森林砍伐导致GHG排放增加和气候变化,随后减少食物生产[102]。

天气事件(如干旱、洪水和热浪)与降雨模式减少、土壤肥力下降和因化肥使用增加导致的酸雨相关[103]。此外,气候变化改变供应链、运输、产量、生物质食物组成、营养质量和食物价格。所有这些影响共同增加了加工食品和高热量饮食的消费,从而提高腹部肥胖的发生率[104]。

空气污染还可通过影响食物生产、质量和消费来影响饮食模式。暴露于空气污染物(如PM2.5和氮氧化物[NOx])可降低作物产量和营养素含量,可能导致加工和高能量密度食品的消费增加[105]。此外,空气污染与氧化应激和炎症增加相关,这可能改变食欲调节和食物偏好,促进高热量和高脂肪食品的消费[106]。这些饮食模式变化可进一步加剧肥胖和代谢紊乱的风险。

此外,大气中CO₂浓度升高导致植物蛋白含量和微量营养素(如钙、铁和锌)减少。例如,C3谷物和块茎(如水稻、小麦、大麦和马铃薯)的蛋白质含量下降了7-15%[107]。因此,气候变化和空气污染具有明显的营养效应,可减少或恶化食物供应和饮食多样性。

---

## 5. 气候变化适应与缓解策略

气候变化和空气污染是加速抗菌素耐药性、食源性和空气传播疾病以及代谢紊乱的全球性威胁。气候变化降低作物产量及其微量营养素含量,破坏食物供应链并增加肥胖率[108]。

最大限度地减少GHG排放将有助于在很大程度上减少气候变化的影响[109]。化石燃料的使用增加GHG排放、肥胖和代谢功能障碍。增加体力活动(如步行或骑自行车)可降低肥胖患病率[110]。具有低微环境影响的可持续饮食是安全的,可帮助减少肥胖及其严重后果。减少肉类消费可显著减少GHG产生,从而间接影响作物生长[111]。

将植物性蛋白(如大豆、豆类和坚果)纳入饮食被认为是一种潜在策略,可减轻气候变化和污染诱导的肥胖的影响[112]。这些蛋白质来源与动物性蛋白相比具有更低的环境影响,其消费与更好的体重管理和肥胖相关合并症风险降低相关。此外,推广主动交通(如步行和骑自行车)有助于减少空气污染,特别是PM2.5形式的空气污染,这与肥胖风险增加相关[113]。

鉴于高温、污染和极端天气事件等因素对糖尿病的多重威胁,实施各种缓解策略和个人适应措施至关重要。这些策略可能包括在极端高温期间的个人降温技术,通过减少GHG排放的生活方式改变来最小化空气污染的影响,以及限制户外活动或佩戴面罩以尽量减少高水平空气污染的暴露[114,115]。

此外,已证明寒冷环境中BAT激活可增加骨骼肌中的脂质氧化和葡萄糖摄取,从而改善胰岛素敏感性[32]。这突出了寒冷暴露作为糖尿病管理治疗方法的潜在益处。此外,从车辆交通转向骑自行车将增加体力活动水平并有助于减少GHG排放,这可能最终降低T2DM的发病风险[116]。推广主动交通和鼓励采用低碳交通模式可带来显著的健康益处,同时解决环境问题。

---

## 6. 结论

本综述强调了气候变化和空气污染对脂肪组织功能障碍、肥胖和代谢健康的重大影响。全球变暖相关的气温升高可损害BAT产热和适应性能量消耗,促进肥胖程度增加。空气污染,特别是PM2.5暴露,可诱导WAT炎症、氧化应激和线粒体功能障碍,加剧IR和代谢紊乱的风险。此外,气候变化和空气污染可改变饮食模式,促进高能量密度和加工食品的消费,进一步促进肥胖流行。

肥胖与气候变化之间的双向关系在现有文献中显而易见。气候变化的影响,特别是环境温度升高,预计将导致肥胖和T2DM发病率升高,部分原因是体力活动水平降低。随着全球气候持续变化,制定和实施个人和集体策略对于最大限度地减少对公共卫生的不利影响至关重要。

减少气候变化和空气污染对代谢健康的不利影响需要实施减少GHG排放、改善空气质量和促进健康饮食习惯的政策和干预措施。这些可能包括推广可再生能源、应用节能技术和鼓励可持续土地利用实践。此外,专注于促进健康饮食习惯和减少加工食品摄入的公共卫生倡议可促进个人健康和环境可持续性。

---

**作者贡献:** 概念化,D.A.;调查,P.C.、R.S.和D.A.;写作——原稿准备,P.C.、R.S.和D.A.;写作——审阅和编辑,R.S.、N.H.-P.、M.M.和D.A.;可视化,D.A。所有作者均已阅读并同意手稿的发表版本。

**数据可用性声明:** 本研究中未创建或分析新数据。数据共享不适用于本文。

**利益冲突:** 作者声明无利益冲突。

---

## 缩略语

ACC 乙酰辅酶A羧化酶 AHR 芳烃受体 ATGL 脂肪甘油三酯脂肪酶 BAT 棕色脂肪组织 BeAT 米色脂肪组织 BMI 体重指数 BPA 双酚A CFC 氯氟烃 CREB-α cAMP反应元件结合蛋白α CVD 心血管疾病 DDE 二氯二苯基乙烯 DDT 二氯二苯基三氯乙烷 DGAT2 二酰甘油O-酰基转移酶2 ER 内质网 FFA 游离脂肪酸 FGF21 成纤维细胞生长因子21 GDF-15 生长分化因子15 GHG 温室气体 GLUT1 葡萄糖转运蛋白1型 GLUT4 葡萄糖转运蛋白4型 HFC 氢氟烃 HDL 高密度脂蛋白 HOXC9 同源框蛋白C9 ICE 间歇性寒冷暴露 IGFBP3 胰岛素样生长因子结合蛋白3 IL-6 白细胞介素-6 IR 胰岛素抵抗 iWAT 腹股沟白色脂肪组织 LPL 脂蛋白脂肪酶 LYG6 淋巴细胞抗原6复合物,基因座G MEHP 单-2-乙基己基邻苯二甲酸酯 NF-κB 核因子-κB NOx 氮氧化物 NST 非颤抖性产热 PDK1 磷酸肌醇依赖性激酶-1 PGC-1α 过氧化物酶体增殖物激活受体-γ共激活因子-1-α PFAS 多氟烷基物质 PFOA 全氟辛酸 PFOS 全氟辛烷磺酸盐 PI3K 磷脂酰肌醇3-激酶 PKB 蛋白激酶B(或Akt) PM 颗粒物 PM2.5 粒径达2.5μm的颗粒物 PPARα 过氧化物酶体增殖物激活受体-α PPARγ 过氧化物酶体增殖物激活受体-γ ROS 活性氧 sWAT 皮下白色脂肪组织 T2DM 2型糖尿病 T3 三碘甲状腺原氨酸 T4 甲状腺素 TG 甘油三酯 TN 热中性 TNFα 肿瘤坏死因子α UCP1 解偶联蛋白1 vWAT 内脏白色脂肪组织 WAT 白色脂肪组织